Modulation of sensory function by high glucose-induced oxidative stress: Role of TRPV1 receptors by Lam, Doris
 MODULATION OF SENSORY FUNCTION BY HIGH GLUCOSE-INDUCED 
OXIDATIVE STRESS: ROLE OF TRPV1 RECEPTORS 
 
 
A Thesis Submitted to the College of 
Graduate Studies and Research 
In Partial Fulfillment of the Requirements 
For the Degree of Master of Science 
In the Department of Physiology 
University of Saskatchewan 
Saskatoon 
 
By 
 
Doris M. Lam 
 
 
 
 
 
 Copyright Doris M. Lam, April, 2012. All rights reserved. 
 
 
 
 
 
 
 
 
 
 
 
i 
 
PERMISSION TO USE 
 
In presenting this thesis in partial fulfilment of the requirements for a Postgraduate degree from 
the University of Saskatchewan, I agree that the Libraries of this University may make it freely 
available for inspection.  I further agree that permission for copying of this thesis in any manner, 
in whole or in part, for scholarly purposes may be granted by the professor or professors who 
supervised my thesis work or, in their absence, by the Head of the Department or the Dean of the 
College in which my thesis work was done.  It is understood that any copying or publication or 
use of this thesis or parts thereof for financial gain shall not be allowed without my written 
permission.  It is also understood that due recognition shall be given to me and to the University 
of Saskatchewan in any scholarly use which may be made of any material in my thesis. 
 
 Requests for permission to copy or to make other use of material in this thesis in whole or 
part should be addressed to: 
 
 
 Head of the Department of Physiology 
 University of Saskatchewan 
 Saskatoon, Saskatchewan  S7N 5E5 
 
 
 
 
 
 
 
 
 
ii 
ABSTRACT 
Diabetes can have a devastating effect on sensory nerves often leading to clinical symptoms of 
pain abnormalities termed diabetic sensory neuropathy (DSN).  Converging evidence 
demonstrate that oxidative stress plays a pivotal role in DSN as a result of elevated reactive 
oxygen species (ROS) induced by hyperglycemia  and lead to sensory neuron injury.  However, 
the cellular and molecular mechanisms initiating neuronal dysfunction in DSN are still poorly 
understood.  The present thesis investigated the effects of high glucose-induced oxidative stress 
on sensory function mediated by the activation of purinergic (P2X) and vanilloid (TRPV1) 
receptors expressed in nociceptive neurons from neonatal mouse dorsal root ganglion (DRG).  
Primary cultures of lumbar DRG neurons were prepared to characterize sensory function during 
control (5 mM glucose) and high glucose (25 mM glucose) conditions using 
electrophysiological, live imaging and biochemical techniques.  Interesting, while characterizing 
TRPV1 channels following repetitive applications of capsaicin, I noticed two distinct responses 
in TRPV1 activity: a „monophasic‟ response, commonly observed as a run-down of peak 
currents; and a „biphasic‟ response characterized as a gradual potentiation followed by a run-
down of peak currents. The latter response is a novel behaviour that had not been characterized 
under control condition, and this prompted further investigations.  I revealed that the gradual 
potentiation was independent of calcium entry, and was mediated by PKC .   Under the high 
glucose condition, the two responses remained unaffected; however, I observed an enhancement 
of TRPV1-mediated currents, while P2X-mediated currents seemed to be unaffected. 
Furthermore, I demonstrated that the enhancement of current can be prevented with the use of 
antioxidants. This suggests that the enhancement of TRPV1 activity by high glucose- induced 
oxidative stress may play an essential role in peripheral sensitization in diabetes.   
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CHAPTER 1 
 
GENERAL INTRODUCTION 
 
Diabetes, a disease characterized by chronic elevation of plasma glucose, results from 
either insufficient insulin production in type 1 diabetes, or from insulin resistance in type 2 
diabetes.  If left unchecked, this elevated glucose, or hyperglycemia, damages the cardiovascular 
system, the retina, the kidney, and the peripheral nerves.  As a result, many diabetics are 
predisposed to life-threatening myocardial infarctions and stroke, and develop blindness, kidney 
failure and experience uncontrolled pain or the loss of sensation in the lower limbs (Vinik et al., 
2003a; Calcutt et al. 2009).  While these system-wide abnormalities can seriously affect the 
quality of life and shorten the life expectancy of diabetic patients, some of these conditions have 
been shown to be a greater burden on the patient and health care system both medically and 
economically.  Affecting nearly 50% of the diabetic population, the clinical syndrome referred to 
as diabetic neuropathy can inflict multiple symptoms reflecting sensory, motor, and autonomic 
nerve dysfunction, depending on the peripheral nerve affected by this pathology.  However, a 
common condition is the display of sensory abnormalities characterized by incapacitating pain or 
loss of protective sensation in the lower limbs, and thus the predisposition to injuries leading to 
poor wound healing, foot ulcerations and gangrene.  If untreated, the end result is lower 
extremity amputation (Boulton et al., 2004).  The severity of diabetic neuropathy has prompted 
considerable research, much of it focused on glucose metabolism and metabolic pathways that 
lead to glucose toxicity in neurons and resulting in neuronal damage in diabetic neuropathy 
(reviewed by Tomlinson & Gardiner, 2008).  However, the cellular and molecular mechanisms 
that are affected by glucose neurotoxicity and contributing to the manifestations of these 
symptoms remain poorly understood.  In this thesis, I am studying mechanisms that affect 
sensory neurons from the dorsal root ganglion (DRG), neurons that are relevant in pain 
processing and contribute to the deleterious sensory abnormalities of diabetes, to help in the 
search for new therapeutic strategies to treat this debilitating condition.  
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1.1 Sensory neurons of the Dorsal Root Ganglion (DRG) 
1.1.1 Origin and differentiation of DRG neurons 
The dorsal root ganglia are a part of the peripheral nervous system that transduces 
afferent sensory information from the external world or the internal environment of the body into 
electrochemical signals that the central nervous system then processes.  The DRG which is 
comprised of a heterogeneous population of sensory neurons that detect a variety of sensory 
modalities, originates from the neural crest in the developing embryo.  The neural crest is found 
at the border of the ectoderm and the neural plate, where folding of the neural plate initiates the 
migration of multipotent neural crest cells (NCC) that will differentiate into sensory neurons of 
the DRG (reviewed by Marmigère & Ernfors, 2007).  The different lineages of sensory neurons 
are determined by the presence of neuronal determination genes, such as neurogenin 1 (Ngn1) or 
2 (Ngn2) in multipotent NCC that expresses Sox10, an important transcription factor in sensory 
neuron lineage (Carney et al., 2006) that has demonstrated its principal role in generating 
different classes of sensory neuron (Ma et al., 1999).  The migration of NCC away from the 
neural crest occurs in three waves of neurogenesis (Marmigère & Ernfors, 2007).  In the first 
wave, the expression of Ngn2 has been shown to commit NCCs into cells that express the 
neurotrophin receptors tyrosine kinase B (TrkB) and/ or C (TrkC).  The second wave of 
neurogenesis involves the proliferation of Sox10-expressing cells that may differentiate into glial 
cells or facilitate the third wave of neurogensis, in which the expression of Ngn1 commits the 
proliferated Sox10-expressing NCCs into a population of DRG neurons containing the 
transcription factor Runx1 and TrkA.  
Runx1 has been shown to be an important transcription factor in differentiating 
peptidergic DRG neurons, which express calcitonin gene-related peptide (CGRP) and substance 
P (SP), from nonpeptidergic DRG neurons during postnatal development.  Gene manipulation 
studies revealed that Runx1 induces changes in neurotrophic factor dependency in DRG neurons.  
Neurons expressing TrkA, the receptor for neurotrophic growth factor (NGF), switch from TrkA 
expression to the expression of Ret, a receptor for the glial-derived neurotrophic factor (GDNF),  
in response to Runx1 (Chen et al., 2006).  This transition was accompanied by the repression of 
CGRP (Kramer et al., 2006) in DRG neurons, suggesting that Runx1 was critical in segregating 
nonpeptidergic DRG neurons from peptidergic neurons.  In addition, behavioural analysis of null 
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Runx1 mice revealed deficits in thermal and neuropathic pain (Chen et al., 2006), suggesting the 
involvement of this transcription factor in the expression and/ or function of nociceptors in 
sensory neurons of the DRG during development. 
 
1.1.2 Anatomy and Classification of DRG neurons 
The DRG are nodule-like structures situated near the ventrolateral surface of the 
vertebra1 column of the spine.  Each ganglion is a collection of cell bodies of sensory neurons. 
Sensory neurons are classified as pseudo-unipolar, and are characterized by a single axonal 
projection from the distal end of the neuronal soma that traverses for a short distance before 
bifurcating. The bifurcation of the axon sends one axonal projection, identified as the central 
terminal, to the dorsal horn of the spinal cord and the second axonal projection, identified as the 
proximal terminal, is sent to the skin, visceral organs, muscles or joints (Fig. 1-1, Liu & Ma, 
2011).  
Because there are a number of tactile sensory modalities (i.e. temperature, nociception, 
proprioception, pressure, vibration and itch), the ability to identify a specific modality has been 
attributed to the distribution of a heterogeneous population of sensory neurons.  One 
classification scheme is based on the morphological characteristics of DRG neurons: (1) large 
cell bodies (diameter > 35 µm) are typically associated with myelinated A  fibers and transmit 
information on proprioception and vibration; and (2) small (diameter < 25 µm) to medium 
(diameter >25 and <35 µm) cell bodies are typically associated with unmyelinated C fibers or 
thinly myelinated Aδ fibers that are responsible for conducting information on nociceptive 
(thermal or mechanical) stimuli (Lawson 1979 & 2002).  Another classification scheme is based 
on the expression of neuropeptides, i.e. CGRP and SP.  This classification scheme allows for 
further segregation of small DRG neurons into peptidergic and nonpeptidergic neurons (Averill 
et al., 1995; Molliver et al., 1995; Molliver et al., 1997). 
Various types of sensory neurons characterized above are affected during the 
pathological conditions generated by diabetes.  However, small to medium peptidergic DRG 
neurons have been reported to be more vulnerable to diabetes-induced cellular injury and to be  
critical components for the manifestation of diabetic sensory neuropathy (Adeghate, Rashed, 
Rajbandari & Singh, 2006; Johnson, Ryals & Wright, 2008).  
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Figure 1-1.  Differential innervations of the DRG.  Sensory neurons of the dorsal root 
gangliong (DRG) receive sensory information from the external world (i.e. skin) and internal 
environment of the body (i.e. bones and joints, tissues and organs) via the peripheral axon 
terminals of the DRG. The transduced electrical signals from the soma of the DRG neurons are 
then relayed to the dorsal horn of the spinal cord via the central axon terminals of the neuron. 
(Figure modified from Liu & Ma, 2011) 
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1.2  Diabetic sensory neuropathy 
Diabetic neuropathy is the most common health complication associated with diabetes, 
and reflects peripheral nerve dysfunction and/or damage (Vinik et al., 2003a).  A vast majority of 
diabetics display signs of sensory abnormalities that start at the feet and ascend proximally, 
which is referred to as diabetic sensory neuropathy (DSN).  Sensory abnormalities in DSN are 
described as incapacitative pain with or without sensory stimulation or the lack of sensation in 
the lower limbs that predisposes the patients to injuries leading to poor wound healing, foot 
ulcerations and sequelae of events with an end result of limb amputation (Boulton, 2004; 
Guastella & Mick, 2007).  In most cases, the severe pain state (i.e. neuropathic pain) in the lower 
limbs precedes the loss of sensation and is related to long-term diabetes and nerve damage.  
However, in other cases, DSN patients do not exhibit the typical neuropathic pain but rather the 
loss of sensation in the same lower extremity (reviewed by Vinik, 2003b).  Clinical studies have 
highlighted two independent processes that may be associated to the differences in the type of 
sensory abnormality: the degree of nerve fiber regeneration and the degree of axonal atrophy.  It 
was reported that the rate of successful nerve regeneration was greatest in diabetic patients 
exhibiting pain abnormalities in DSN, and the degree of axonal atrophy was greatest among 
diabetic patients exhibiting the loss of sensation in DSN (Behse et al., 1977; Britland et al., 
1990).  However, it remains unknown what factors contribute to the differential sensory 
abnormalities observed in DSN patients. 
Because the degree and magnitude of the painful sensory abnormality in DSN can vary 
across patients, a greater emphasis in the literature has been on understanding the mechanisms 
regulating the neuropathic pain state in DSN.   The incapacitative pain in diabetic patients has 
been described as a burning, throbbing or shooting sensation that can occur spontaneously, 
chronically or intermittently (Dworkin, 2002).  Characterization of the type of pain states have 
included: hyperalgesia, severe pain towards a stimulus that evokes a slight painful sensation, or 
allodynia, severe pain in response to an innocuous stimulus that normally does not induce pain.  
A noninvasive diagnostic aid to evaluate sensory abnormalities was made possible by the use of 
a dermatome map.  Sensory examination (i.e. vibration, thermal, and mechanical stimulation) of 
a dermatome, an area of the skin that sends afferent information to a single spinal nerve of the 
DRG, would identify sensory abnormalities localized to specific DRGs along the spinal cord.   
The abnormal sensation characteristic of DSN (i.e. neuropathic pain or lack of sensation) is
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predominantly localized to the lower limbs (i.e. leg, foot and toes) and is shown to correspond to 
DRGs of the lumbar segments of the spinal cord.  The susceptibility of the lumbar spinal nerves 
of the DRG to the pathogenesis of DSN is thought to be due to its long axonal projection from 
the spinal cord segment to the distal limbs.  Lumbar DRGs have therefore been a prime 
candidate in examining cellular and molecular mechanisms affected by DSN.   
Another diagnostic instrument commonly used is the direct examination of skin biopsies 
looking at the sural nerve that terminates at the epidermis on the lateral side of the ankle and 
foot. Sural nerve biopsies have been used as a valid tool to examine the progression of nerve 
fiber loss in diseases and in treatment-based regeneration and functioning of the nerve fibers 
(Pringle et al., 1974; Griffin et al., 2001).  Clinical investigation into early pathological changes 
in the sural nerves biopsy from diabetic patients (diagnosed with diabetes mellitus for more than 
6 months) revealed an early occurrence of small unmyelinated fiber degeneration, measured as a 
decrease in axon diameter, without any changes in nerve conductance or velocity, but with a 
compensatory increase in the unmyelinated axon density and Schwann cell profile (Malik et al., 
2005).  In contrast, clinical assessment in patients with long term diabetes revealed extensive loss 
of myelinated and unmyelinated fibers with a concomitant decrease in axon diameter, reduction 
in sensory nerve conduction velocity associated with a decrease in myelination, and reduced 
Schwann cell profiles that indicated a reduced capacity for nerve regeneration (Bertelsmann et 
al., 1985; Llewelyn et al., 1991; Malik et al., 2001; Polydefkis et al., 2004).  Because of the 
susceptibility of small unmyelinated fibers to diabetes, it has been suggested that the functional 
and structural changes to these fibers were responsible for the severe pain exhibited by diabetic 
patients. 
Unfortunately, there are no treatments for DSN other than glycemic control and diligent 
foot care (Rathur et al., 2005; Sullivan & Feldman, 2005; Little et al., 2007; Vinik et al., 2003a 
& 2004).  This is in spite of ongoing research addressing the pathogenesis of the disease, with 
the goal to identify mechanism-based treatments.  In particular, the influence of glucose-
mediated pathways in the pathogenesis of DSN involved in the functional changes in sensory 
neurons.  In recent years, research in animal models of diabetes have suggested that 
dysregulation of glucose levels activates multiple distinct metabolic pathways that lead to a 
singular end result: oxidative stress in neurons (see below).   
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1.3 Oxidative stress in diabetes 
It is well established that hyperglycemia mediates oxidative stress through multiple 
mechanisms resulting in the overproduction of reactive oxygen species (ROS).  Four glucose 
mediated pathways have been implicated in the generation of ROS by increased: (1) polyol 
pathway flux; (2) formation of advanced glycation end-products (AGE); (3) activation of protein 
kinase C (PKC) isoforms; and (4) hexosamine pathway flux (reviewed by Brownlee, 2001).  The 
increase in metabolic flux within these pathways has reportedly influenced the electron transport 
chain of the mitochondria. The increase in reducing agents, such as NADH, coupled with the 
depletion of ATP and increase in electron availability resulted in the formation of ROS at the 
proximal portion of the electron transport chain (Vincent et al., 2002; Tomlinson & Gardiner, 
2008).  The inability of the cell‟s antioxidant defense system to compete with the excessive 
amount of ROS rendered the cell vulnerable to oxidative damage, and subsequently altering the 
structure and function of lipids, DNA and protein, which ultimately led to programmed cell 
death.  Other oxidative stress responses have also been suggested to influence ROS production.  
For example, loss of neurotrophic support by insulin and the insulin-like growth factors (IGF-I, 
IGF-II), nerve growth factor and neurotrophin-3 (Chiarelli et al., 2000), as well as altered 
intracellular calcium homeostasis and calcium signalling (Huang et al., 2002; Fernyhough & 
Calcutt, 2010).  Although the cellular mechanisms elicited by ROS remain unclear, it is well 
established that hyperglycemia leads to oxidative stress.  
The effect of oxidative stress has been studied in cell cultures of DRG neurons as a 
simplified model to explore the underlying mechanisms in DSN.  Small to medium sized 
dissociated DRG neurons exposed to a hyperglycemic insult resulted in mitochondrial membrane 
potential dysregulation, mitochondrial swelling and the overproduction of ROS (Russell et al., 
2002; Vincent et al., 2002 & 2005a).  Exposure to mild concentrations of pro-oxidant agents (e.g. 
H2O2) initiated of a transient defense mechanism augmenting the expression of antioxidant 
enzymes to counteract ROS production (Vincent et al., 2009).  However, this defense mechanism 
has been reported to be compromised in DRG neurons exposed to higher concentrations of 
glucose (Vincent et al., 2009).  
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The influence of the glucose-mediated pathways and the accumulation of ROS have led 
to a few hypotheses to explain the role of oxidative stress in peripheral nerve malfunction in 
diabetes.  It was initially hypothesized that the accumulation of cytoplasmic ROS led to the 
initiation of multiple effector mechanisms that triggered apoptosis or programmed cell death in 
DRG neurons (Russell et al., 1999; Vincent et al., 2002; 2005a; 2009).  These studies showed a 
decrease in the number of DRG neurons as early as 2 hours following exposure to high glucose.  
This finding was consistent with previous studies that reported apoptosis in endothelial cells 
involved in micro- and macrovascular injuries leading to retinopathy and nephropathy (Obrosova 
et al., 2003 & 2005).  Unfortunately, the level of hyperglycemia used in these studies was greater 
than those observed in diabetes, which makes the validity and reliability of these findings to 
DSN questionable.  A more recent hypothesis for the development of DSN is based on the 
synaptic malfunction of peripheral nerves due to axonal swelling and retraction, and the inability 
of axonal regeneration (Srinivasan, 2000; Fernyhough & Calcutt, 2010).  Rather than oxidative 
stress-induced apoptosis, Fernyhough and colleagues (2010) reported that elevation of ROS 
triggered mitochondrial dysfunction, which causes axonal dystrophy, but spares neuronal cell 
bodies.  The inability to relay sensory information from the DRG to the dorsal horn neurons of 
the spinal cord seems to be a plausible hypothesis for DSN, although mechanisms resulting from 
elevated cytoplasmic ROS and contributing to functional and structural changes in DRG neurons 
remain poorly understood. 
More recently, oxidative stress has been directly implicated in the onset of diabetic 
autonomic neuropathy.  Autonomic neuropathy is a form of diabetic complication that affects 
autonomic nerves causing autonomic malfunction or dysautonomia. Campanucci et al. (2008 & 
2010) have elucidated the mechanisms underlying the onset of dysautonomia in animal models 
of type 1 and type 2 diabetes.  Hyperglycemia-induced elevation in cytoplasmic ROS caused the 
inactivation of neuronal nicotinic receptors (nAChRs) in sympathetic neurons by targeting 
conserved cysteine residues located near the intracellular mouth of the nAChR channel.  Because 
nAChR “drive” sympathetic synaptic transmission, their inactivation leads to depression in 
ganglionic transmission and reduced sympathetic reflexes.  Importantly, the use of antioxidants 
and neurons expressing mutated nAChRs subunits that lacked the conserved cysteine residues, 
prevented the inactivation induced by hyperglycemia and animals showed normal sympathetic 
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reflexes.  These findings proposed a functional (rather than structural) abnormality in 
sympathetic ganglia induced by diabetes, opening a new window of opportunity for 
therapeutic strategies in the treatment of diabetic neuropathy. Whether cytoplasmic ROS have 
any effect on receptors expressed in the DRG neuron remains unclear. 
 
1.4 Neurotransmitter receptors in DRG neurons involved in nociception 
Nociceptive DRG neurons are comprised of a heterogeneous population of 
neurotransmitter receptors. For example purinergic (P2X) receptors and transient receptor 
potential 1 (TRPV1) have been identified as main players in sensory function, in particular, of 
nociception (Chen et al., 1995; Caterina et al., 1997).  Although these receptors have been 
extensively studied with regards to pain processing, their function during hyperglycemic 
conditions and their possible contribution to DSN remains elusive.  
  
1.4.1 Role of P2X receptors in nociception and diabetes 
P2X receptors are membrane ion channels activated by the binding of extracellular 
adenosine triphosphate (ATP).  They belong to a large family of ion channels widely expressed 
in the nervous system and play an important role in many physiological and pathological 
processes (Grubb & Evans, 1999).  The DRG neurons express a variety of P2X receptors (Chen 
et al., 1995; Lewis et al., 1995).  To date, seven different subclasses have been reported (P2X1-7; 
North, 2002).  The highest proportion of mRNA transcript expressed in DRG neurons are the 
homodimeric P2X3 receptor, followed by P2X2 receptors and the heterodimeric P2X2/3 
receptors (Chen et al., 1995; Lewis et al., 1995; Stebbing et al., 1998).  Notably, these 3 
subclasses are distinct in their phenotypic responses: (1) fast-inactivating currents have been 
associated with P2X3 receptors; (2) slow-inactivating currents associated with P2X2 receptors; 
and (3) mixed response of fast and slow inactivated currents were expressed in P2X2/3 receptors 
(Grubb & Evans, 1999).  Remarkably, in vitro studies have shown that greater than 80% of DRG 
neurons expressed fast-inactivating currents reflecting P2X3 receptors (Grubb & Evans, 1999). 
Studies from genetic models in which the expression of P2X3 receptors was manipulated 
revealed their critical role in processing of thermal and mechanical nociception (reviewed by 
Jarvis, 2003).  Deletion of P2X3 receptors caused a loss of the rapidly desensitizing ATP-evoked 
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currents that paralleled normal responses to noxious mechanical and thermal stimuli and reduced 
formalin-induced pain behaviour (Souslova et al., 2000).  In addition, down regulation of P2X3 
receptors by antisense oligonucleotide treatment decreased P2X3-mediated currents (Dorn et al., 
2001) and reduced mechanical hyperalgesia (Barclay et al., 2002) in models of inflammation and 
chronic pain.   
Because P2X3 is the predominant purinergic receptor subtype expressed in DRG 
neurons, its role in pain is relatively understood.  However, understanding of the role of P2X2 
and P2X2/3 receptors remains limited as a result of their scarcity in the literature of pain.  A 
significant contribution was provided by Cockayne et al (2005), who studied primary cell culture 
of DRG neurons from null mice lacking the P2X2 subunit or from a double null mice lacking the 
P2X2 and P2X3 subunits. The study revealed that sensory neurons from P2X2 null mice 
responded to ATP with only transient inward currents, while neurons from P2X2/P2X3 double 
null mice had minimal to no response to ATP. These data indicated that P2X receptors on 
sensory ganglion neurons involved almost exclusively P2X2 and P2X3 subunits. Consistently, 
both P2X2 null and P2X2/P2X3 double null mice had reduced pain-related behaviours in 
response to intraplantar injection of formalin, suggesting that these P2X subtypes may not be 
crucial to nociceptive processing.   
Only recently have the roles of P2X receptor subunits in animal models of diabetes been 
investigated.  In diabetic animal models, in which the insulin-producing  cells of the pancreas 
are destroyed by streptozotocin (STZ; Schnedl, Ferber, Johnson & Newgard, 1994), there was an 
increase in expression and function of purinergic receptors in mice (Migita et al., 2009) and rats 
(Gy, Li, Liu & Huang, 2011).  Migita et al (2009) reported an increase in P2X2 and P2X3 
mRNAs at 5 days following STZ injection, which remained stable at 14 days.  This increase in 
mRNA transcripts paralleled the onset and sustained hyperalgesic response during von Frey 
filaments test, a test for mechanical nociception.  More recently, Gy et al. (2011) examined P2X-
mediated currents from DRG neurons following 2 weeks of STZ-induced diabetes in rats. The 
study revealed ATP-evoked currents that resembled the P2X3 subtype and observed a two-fold 
increase in inward current versus control.  This potentiation paralleled the increase in P2X3 
expression in the plasma membrane of DRG neurons, while total expression of the P2X3 
receptors remained unaltered.  To supplement their findings, behaviour analysis using the von 
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Frey test also revealed mechanical hypersensitivity that was alleviated by nonspecific P2X 
receptor antagonist PPADS.  Due to the low specificity of the antagonist, it is unknown whether 
P2X2 or P2X2/3 receptors were contributors to diabetes-induced mechanical hyperalgesia. 
Nevertheless, these studies indicate that P2X receptors are influenced under diabetic conditions.  
Due to recent evidence on the influence of oxidative stress in diabetes, the affects of 
oxidative stress on the purinergic receptor has also been described in cultured HEK 239 cells 
(Mason et al., 2004; Coddou et al., 2009).  Mason et al. (2004) reported selected modulation of 
purinergic receptors as a result of hypoxia-induced ROS production.  Under acute hypoxic 
conditions, P2X2 receptors had shown a significant decrease in current amplitude compared to 
cells in normoxic conditions.  In addition, modulation of ROS production via the mitochondrial 
electron transport chain altered the current magnitude in P2X2 receptors.  A decrease in ROS 
production via the inhibition of mitochondrial complexes 1 and 3 caused a transient increase in 
ATP-induced current, while an increase in ROS production via inhibition of complex 3 caused a 
transient decrease in current magnitude.  Although Mason et al. (2004) described the influence of 
ROS on P2X2 receptors, the exact mechanism by which ROS altered the structure and/or 
function of the ion channel remains unknown.  Moreover, the authors reported that this 
modulation observed in P2X2 receptors had no effect on homodimeric P2X3 and heterodimeric 
P2X2/3 receptors.   Contrary to these findings reported by Mason et al. (2004), a recent study by 
Coddou et al. (2009) reported a potentiation in current magnitude for P2X2 receptors in cells in 
response to H2O2, a type of ROS.  The authors described this potentiation as a result of 
oxidization of intracellular cysteine residues.  When cells were exposed to reducing agents, 
ROS-mediated potentiation of current magnitude was prevented.  However, the involvement of 
this mechanism in the context of diabetes remains poorly understood. Interestingly, these in vitro 
studies implicate P2X2 receptors as the sole target of acute oxidative stress, contrasting the effect 
seen in diabetic animal models in which both P2X2 and P2X3 were implicated.    
 
1.4.2 Role of TRPV1 receptors in nociception and diabetes 
In addition to P2X receptors, the TRPV1 receptor has been extensively studied in pain 
processing and may also be influenced by DSN.  Ablation of TRPV1 led to deficient responses 
to noxious (thermal or mechanical) stimuli (Caterina et al., 2000; Mishra et al., 2011), suggesting 
a pivotal role for TRPV1 in the detection and processing of pain.   In addition, pharmacological 
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manipulations of the receptor demonstrated that the TRPV1 receptor is a polymodal detector 
activated by a number of stimuli: capsaicin, protons (pH), heat (>42°C), and arachidonic acid 
(Caterina et al., 1997).  TRPV1 is a nonselective cation channel that depolarizes the membrane 
potential of neurons due to its high permeability to calcium ions (Wood et al., 1988; Docherty et 
al., 1996; Chung et al., 2008).  Once activated, the receptor undergoes two forms of 
desensitization: 1) „acute desensitization‟, a reduction in current amplitude during a single 
exposure of a stimulus; or 2) „tachyphylaxis‟, a pharmacological and functional diminuation of 
peak current amplitudes in response to repeated exposure to a stimulus (Koplas et al., 1997).  
The ability of the receptor to undergo an overall diminished response as a result of prolonged or 
repeated exposure to a stimulus ignited the investigation of this receptor as a possible therapeutic 
target for various pain conditions (i.e. inflammation, hyperalgesia, neuropathic pain and etc.).  
However, understanding molecular mechanisms influencing the activity of the TRPV1 receptor 
and its involvement in various pathological pain states has also prompted considerable research.  
Capsaicin, an agonist of TRPV1, is found in hot peppers, and has been commonly used to 
activate the receptor under experimental conditions.  The agonist is a lipophillic compound that 
diffuses through the plasma membrane and binds to intracellular sites on the N- and C- termini 
(Jung et al., 1999 & 2002); in particular, the TM2-TM3 linker, and on the channel-lipid interface 
of TM2 andTM3 (Jordt & Julius, 2002), thereby allowing entry of current.  The increase in pain 
sensitivity in various pathological pain conditions has been attributed to amplification of TRPV1 
activity (reviewed by Patapoutian, Tate & Woolf, 2009).  Sensitization of the TRPV1 receptor 
has been shown to be caused by proinflammatory mediators that activate PKC and results in the 
enhancement in the membrane current of TRPV1 receptors (Dai et al., 2004; Moriyama et al., 
2005; Sikand & Prekumar, 2007; Zhang et al., 2007).  In addition, increased trafficking of the 
receptor to the membrane through retrograde transport of neurotrophic factors (i.e. nerve growth 
factor and glial cell line-derived neurotrophic factor) and the activation of phosphoinositide 3-
kinase signalling cascade has also been shown to enhance TRPV1 activity in DRG neurons 
(Amaya et al., 2004; Zhuang et al., 2004; Stein et al., 2006;  Malin et al, 2006; Zhu & Oxford, 
2007). 
Interestingly, sensitization of TRPV1 receptors has been reported in the STZ-induced 
diabetic model in rodents (Hong & Wiley, 2005; Pabbidi et al., 2008 a & b).  These studies 
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confirmed that diabetic rodents exhibit a reduced latency to withdrawal from a noxious thermal 
stimulus compared to age-match controls.  This sensitization was correlated with increased 
inward currents and increased duration of capsaicin evoked currents in DRG neurons.  However, 
these observations were based on animal models with long standing diabetes induced by STZ.  
Whether STZ can influence ion channel regulation and pain sensitivity remains poorly 
understood.  It has been observed that DRG neurons in culture exposed to STZ exhibited a 
higher level of ROS and an increase in TRPV1 activity and expression, suggesting STZ as a 
possible confound variable to consider (Pabbidi et al., 2008a).   
Oxidative stress caused by pharmacological exposure to reducing and oxidizing agents 
has been demonstrated to covalently modify cysteine residues in the extracellular and 
cytoplasmic domains of TRPV1 and in turn, influenced the sensitivity of the receptors in 
HEK293 cells (Susankova et al., 2006; Chuang & Lin, 2009).  These studies revealed that 
oxidative modification, in particular, via the formation of inter-cysteine disulfide bonds within 
the cytoplasmic domain of the ion channel, sensitized the receptor in response to repeated 
applications of capsaicin. However, it remains unclear from these studies if hyperglycemia-
dependent oxidative stress can induce changes in TRPV1 activity directly or as a consequence of 
the length of the disease.   
 
1.5 Objectives 
 This thesis investigated the role of high glucose (HG)-induced oxidative stress on P2X 
and TRPV1 receptors expressed on mice lumbar sensory neurons in culture. The central 
hypothesis of this thesis is that elevated cytoplasmic ROS, or oxidative stress, as a result of high 
glucose for seven days will potentiate P2X and TRPV1 membrane currents.  To examine this, I 
used electrophysiological, live imaging and biochemical tools to understand the function of these 
neurotransmitter receptors in sensory neurons under control and high glucose conditions. The 
ultimate objective of this study is to generate data that may help in the development of new 
therapeutic targets for the treatment of diabetic-related complications. 
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CHAPTER 2 
 
ELECTROPHYSIOLOGICAL CHARACTERIZATION OF TRPV1-MEDIATED 
CURRENTS IN SENSORY NEURONS: MONOPHASIC AND BIPHASIC RESPONSES 
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2.1 Introduction  
Capsaicin (CAP) is a lipophilic chemical present in hot chili peppers that activates a 
nonselective cation channel, the transient receptor potential vanilloid 1 channel (TRPV1, 
Tominaga & Tominaga, 2003).  CAP binds to various sites within the TRPV1 receptor, including 
the TM2-TM3 intracellular linker, within the channel-lipid interface in the TM2 and TM3 
membrane domains, and at intracellular sites in the N- and C-termini (Jung et al., 2002; Jordt & 
Julius, 2002; Immke & Gavva, 2006).  Exposure of sensory neurons of the dorsal root ganglion 
to CAP increases intracellular calcium levels through the TRPV1 receptor, which is highly 
permeable to the divalent cation (Wood et al., 1988).  In addition, once TRPV1 channels have 
been activated by CAP, they can undergo desensitization that affects the magnitude and kinetics 
of the CAP-evoked currents.  Different desensitization mechanisms cause the reduction of the 
CAP-evoked current.  Acute desensitization is responsible for the current transient observed 
during a single application of CAP, while tachyphylactic desensitization is observed during 
repetitive CAP applications over a period of time (Petersen et al., 1996; Oh et al., 1996; Koplas 
et al., 1997).  Desensitization by tachyphylaxis is dependent on extracellular Ca
2+
 and leads to 
the successive diminishment of TRPV1-mediated currents (Koplas et al., 1997).  It has been 
proposed that a rise in intracellular Ca
2+
 activates calcineurin and leads to de-phosphorylation 
and desensitization of the CAP-sensitive TRPV1 channel (Docherty et al., 1996; Mohapatra & 
Nau, 2005; Por et al., 2010), providing a physiological role for desensitization of TRPV1 
channels following repetitive activation in blocking pain transmission.  
In the present study, I observed that lumbar DRG neurons could be subdivided in two 
groups based on the type of responses elicited following repetitive CAP applications.  TRPV1 
currents displayed two types of responses: (1)  a „monophasic response‟ with a diminuation of 
peak current typical of tachyphylactic desensitization; or (2), a „biphasic response‟ composed of 
an initial gradual potentiation of the peak current followed by its desensitization by 
tachyphylaxis.  Interestingly, replacing external calcium by barium, a divalent cation commonly 
used to examine Ca
2+
 regulation of ion channels, revealed three characteristics of the TRPV1 
responses to repeated CAP applications: 1) the potentiation of  CAP-evoked current in the 
biphasic response was independent of extracellular calcium, 2) the time course of the current 
potentiation was dependent on extracellular calcium, and 3) the tachyphylactic desensitization of 
CAP-evoked currents was dependent on extracellular calcium, as described by previous reports 
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(Koplas et al., 1997; Docherty et al., 1997; Mohapatra & Nau, 2005).  In addition, with the help 
of an inhibitor of the beta isoform of protein kinase C (PCKβ), I demonstrated that activity of 
this kinase is essential for the potentiation part of the biphasic response following repetitive CAP 
application. I also confirmed that the two different patterns of CAP responses were present in 
calcitonin-gene related peptide (CGRP)-positive neurons, consistent with the role of these 
neurons in pain perception and processing also in the adult.  Collectively, these results 
demonstrate that TRPV1 from nociceptive lumbar DRG neurons display two forms of responses 
following successive CAP applications, suggesting that they may play different roles in 
mechanisms of pain. 
 
2.2 Materials and Methods  
 
2.2.1 Primary culture 
All experiments were approved by the University of Saskatchewan‟s Animal Research 
Ethics Board, and adhered to the Canadian Council on Animal Care guidelines for humane 
animal use.   Primary DRG cultures for neonatal C57BL/6 mice between postnatal day 1 to 3 
(P1-P3) were used for the preparation of the dissociated DRG cultures.  The methods used to 
dissociate the neurons were similar to the protocol used to dissociate superior cervical ganglion 
neurons (Campanucci et al., 2008; McFarlane & Cooper, 1992).  Briefly, mice were euthanized 
by cervical transection in a sterile environment.  Lumbar (L1 to L5) DRGs from the spinal cord 
were collected into a Petri dish with serum-containing media (L15 supplemented with vitamins, 
cofactors, penicillin-streptomycin and 5 mM glucose, and 10% horse serum).  Small iris scissors 
were used to trim the remaining nerve roots from the ganglia.  Once cleaned, the ganglia were 
submerged in an enzymatic solution (0.1% trypsin; Worthington, Freehold, NJ, USA) buffered 
with 1 M of HEPES (pH 7.4), and incubated at 37°C for 30- 45 min in a water bath for 
enzymatic dissociation of ganglia. 
Next, DRGs were mechanically dissociated by using a fire-polished pipette.  The 
dissociated neurons were rinsed twice with serum-containing media to inactivate trypsin. The 
resulting cell suspension was transferred to growth media consisting of L-15 supplemented with 
vitamins, cofactors, penicillin-streptomycin, 5% rat serum, 7S Nerve Growth Factor (10 ng/ ml) 
and 5 mM of glucose. The neurons were plated on laminin-coated coverslips attached to 
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modified 35 mm tissue culture dishes.  Cells were maintained at 37°C in a 95% air and 5% CO2 
environment and fed every 3-4 days with growth media.  To eliminate non-neuronal cells, 
cultures were treated with cytosine arabinoside (10 M; Sigma, St. Louis, MO, USA) from day 1 
to day 3.   Cells were allowed to recover from stress and axotomy for one week prior to any 
treatment or experimental procedure.   Cultured neurons were maintained in medium containing 
either 5 mM glucose (control) or switched to 25 mM glucose (high glucose), for 1 week.  Two 
weeks following the day of culture, cells were subjected to electrophysiological experiments. 
The method used to isolate of DRG neurons from adult transgenic CGRP- eGFP CD1 
mice were similar to the protocol used in this study with minor modification based on the 
protocol used by Burkey et al. (2004).  Briefly, dissected and cleaned lumbar DRGs were 
incubated at 37 °C in 0.1% collagenase (Worthington type 2, Calbiochem, San Diego, CA, USA) 
for 30 minutes and then 0.1% trypsin for an additional 30 minutes. After titration, the dissociated 
neurons were rinsed with Dulbecco‟s modified eagle medium (DMEM, Gibco, Carlsbad, CA, 
USA) containing 10% horse serum, followed by resuspension in growth media containing 
DMEM supplemented with vitamins, cofactors, penicillin-streptomycin, 5% rat serum, 7S Nerve 
Growth Factor (10 ng/ ml) and 5 mM of glucose.  Maintenance of cultured adult neurons was as 
indicated for neonatal neurons. 
2.2.2 Electrophysiology 
CAP-evoked current were recorded using the whole-cell patch-clamp technique (Hamill 
et al., 1981).  Patch pipettes were made from borosilicate glass (WPI, Sarasota, FL, USA)  using 
a vertical puller (PC 10; Narishige Scientific Instrument Lab., Tokyo, Japan) and were fire-
polished with the help of a microforge (MF 900; Narishige).  Micropipettes had a resistance of 5-
10 M  when filled with intracellular recording solution, and formed gigaseals of 1-8 G .  
Recording electrodes were filled with the following solution (in mM): 60 KAc, 70 KF, 5 NaCl, 1 
MgCl2, 1 CaCl2, 2 MgATP, 10 EGTA, and 10 HEPES, and pH was adjusted to 7.2 with KOH.  
Junction potentials were cancelled at the beginning of the experiment. The external solution 
contained (in mM): 140 NaCl, 5.4 KCl, 0.33 NaH2PO4, 0.44 KH2PO4, 1 MgCl2, 1 CaCl2, 10 
HEPES, and 5 glucose, and pH was adjusted to 7.4 with NaOH.   For barium experiments, 1-2 
mM of BaCl2 was used in place of CaCl2 in the external solution. Whole-cell currents or 
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membrane potentials were recorded at room temperature with the aid of an Axopatch 200B 
amplifier (Axon Instruments Inc., Union City, CA, USA) equipped with a 1 G  headstage 
feedback resistor and sampled at 5 kHz with a Digidata 1440A.  Voltage clamp protocols, data 
acquisition and analysis were performed using pCLAMP 10 software (Axon Instruments) and 
Origin 7 (OriginLab Coorporation, Northampton, MA, USA).  Once the whole-cell configuration 
was achieved, cells were allowed to stabilize for 5 min before recording.  Using a fast-step 
perfusion system, neurons were exposed to control or CAP (5 µM) solution at a rate of 1 
mL/min.  Tetrotodoxin (TTX, 1 μM) was added to both control and CAP solutions to 
continuously block voltage-gated sodium channels.   
2.2.3 Statistics 
For comparisons of mean current density, I used the unpaired Student‟s t-test. 
Comparisons of ratio of ionic currents, integrated current area, and percentages, I used the non-
parametric Mann-Whitney test.  
 
 
2.3 Results 
 
2.3.1 Repetitive applications of capsaicin elicited monophasic and biphasic responses of 
TRPV1-mediated currents 
Small to medium sized dissociated lumbar DRG neurons (15-25 pF) were exposed to a 
series of brief repetitive applications of CAP (5 µM for 1 s, at 15 s intervals) to examine TRPV1-
mediated currents in whole-cell patch clamp mode.  Consistent with previous reports, repetitive 
applications of CAP evoked a monophasic response depicted by the run-down (or 
desensitization) of the TRPV1-mediated peak currents in some cells (Fig. 2-1A, left column).  
Unexpectedly, given the same number of CAP applications, a subgroup of neurons displayed a 
biphasic response depicted by a gradual potentiation of the peak TRPV1-mediated current 
followed by its desensitization (Fig. 2-1A, right column).  To quantify the number of cells 
exhibiting the monophasic or biphasic response, I used a threshold criterion of 50% increase in  
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Figure 2-1. CAP-evoked currents show two distinct types of responses. (A)Whole-cell 
currents in voltage clamp mode were obtained from a series of 1 s capsaicin (CAP) applications 
(5 µM) at 15 s intervals.  Repetitive CAP applications revealed two behaviors in TRPV1-
mediated currents. The monophasic response displayed desensitization in TRPV1-mediated 
currents (left column, n=10), while the biphasic response displayed an initial potentiation 
followed by desensitization in TRPV1-mediated currents (left column, n=7).  Superimposition of 
these current traces is represented following every 3 applications of CAP. (B) The distribution of 
these responses is summarized in the bar graph where a greater percentage of neurons displayed 
the monophasic response (black) relative to the biphasic response (white). (C) The bar graph 
summarizes the mean SEM initial peak current density (I1) of the monophasic and biphasic 
response following the first CAP application. * indicates statistical significance between 
conditions at a level of p<0.05.  The distinct difference in I1 between responses helped to identify 
the two responses to repetitive CAP-applications during the course of the experiments.  
 
 
CAP (5 M) CAP (5 M) 
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the maximum peak current relative to the initial peak amplitude of CAP-evoked currents in a 
series.  This 50% value was used because it best represented the two distinct types of responses 
in TRPV1 activity.  Based on the threshold criterion, monophasic responses occurred in 59% of 
cells (n=10) while biphasic responses occurred in 41% of cells recorded (n=7, Fig. 2-1B).  To 
determine whether there was a difference in the magnitude of the initial CAP-evoked current (I1), 
I compared the peak current density of I1 in monophasic and biphasic responses (Table 2-1).  The 
peak current density of I1 for the monophasic response was significantly larger, being 
approximately twice the amplitude of I1 in the biphasic response (p<0.05, Fig. 2-1C). This 
distinctive characteristic helped to identify the two responses to repetitive CAP-applications 
during the course of the experiments.  
2.3.2 Differential effects of calcium on the desensitization of the monophasic and the 
potentiation of the biphasic response 
To further characterize these responses, I next investigated mechanisms that underlie the 
two types of responses.  I first concentrated on the tachyphylactic desensitization observed over 
repetitive CAP applications.  Because both responses displayed this run-down effect, I compared 
the degree of desensitization of the maximal CAP-evoked current (Imax) in both the monophasic 
and biphasic responses relative to the 15
th
 CAP-evoked current (I15)  generated in the series 
(Table 2-1).  Interestingly, the degree of desensitization, quantified as the percent change in the 
peak current density and integrated area, were not statistically different between responses 
(p>0.05), suggesting that it may involve the same mechanisms.  Previous works have shown that 
the degree of tachyphylaxis was dependent on calcium entry (Koplas et al., 1997; Mohapatra et 
al., 2003).  Therefore, to confirm that the tachyphylactic desensitization of CAP-evoked currents 
observed in the present study was consistent with previous reports in DRG neurons, Ca
2+
 ions 
were replaced in the extracellular solution by equal concentration of barium (Ba- ECF, Fig. 2-2).  
Interestingly, all neurons recorded in Ba-ECF revealed whole-cell currents that were smaller in 
peak amplitude (Fig. 2-2A, right) compared to neurons recorded in standard calcium 
extracellular solution (Ca- ECF; Fig. 2-2A, left).  The CAP-evoked responses displayed a 
gradual potentiation that did not desensitize but remained stable in peak current amplitudes, 
suggesting that calcium entry is required to initiate desensitization of the receptor, as previously 
described.   
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Table 2-1 Quantitative assessment and comparison of current traces between monophasic 
and biphasic responses from DRG neurons. 
 Monophasic 
(n=10) 
Biphasic 
(n=7) 
Peak current density 
(pA/pF) 
I1 24.47±4.46 13.25±1.87* 
I max 22.68±5.41 28.44±4.56 
 Integrated area (pC) ∫I1 
0.40x10
7
±0.11x10
7
 0.22x10
7
±0.40x10
7
 
∫Imax 
0.53x10
7
±0.11x10
7
 0.66x10
7
±0.18x10
7
 
Percentage of 
desensitization (%) 
Imax/ 
I15 55.88±5.25 61.02±4.00 
 
* Indicates statistical difference between type of responses at a level of p<0.05. 
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Figure 2-2. Potentiation in CAP-evoked currents is independent of extracellular calcium. 
(A) Whole-cell currents for cells recorded in Ba-ECF (1-2 mM) were obtained from a series of 
1s CAP applications (5 µM) at an interval of 15 s in voltage clamp mode.  In all neurons, 
successive CAP applications revealed a gradual potentiation in CAP-evoked current that leveled 
off and remained stable in current traces (left column). For comparison of potentiation, the right 
column is an example of whole-cell current traces of a neuron displaying the biphasic response 
recorded in Ca-ECF. (B) Bar graph summarizes the mean SEM percentage of potentiation 
(measured as of the percentage of I 1 relative to Imax). (C) The scatter plot summaries the mean 
SEM peak current density for neurons recorded in Ba-ECF (red) and those that displayed the 
biphasic response in Ca-ECF (black), revealing a greater number of CAP applications to reach 
Imax peak amplitude for neurons recorded in Ba-ECF relative to those in Ca-ECF.  
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To study the dependency of potentiation of CAP-evoked current on Ca
2+
 ions, I recorded 
in extracellular Ba-ECF.  Under this recording condition, all neurons displayed current traces 
that potentiated, similar to the potentiation in the biphasic response recorded in standard Ca-ECF 
(Fig. 2-2A).  To quantify the degree of potentiation in TRPV1-mediated currents for cells 
recorded in Ba-ECF and Ca-ECF, I examined the percentage increase from I1 relative to Imax.   
Despite the reduction of charge generated in CAP-evoked currents recorded in Ba-ECF, the 
percentage of potentiation was no different from neurons recorded in Ba-ECF or Ca-ECF, (Fig. 
2-2B).  In addition, it appeared that the onset for maximal peak current amplitude required more 
CAP applications for neurons recorded in Ba-ECF (i.e. 13 applications), relative to those 
recorded in Ca-ECF (i.e. 6 applications, Fig. 2-2C).  Arguably, this would suggest that the time 
course to generate maximal current amplitude is influenced by Ca
2+
 or Ca
2+
 dependent 
signalling.  These findings revealed that although the removal of extracellular calcium strongly 
diminished the magnitude of CAP-evoked current, which was therefore mediated by barium and 
monovalent cations it did not affect the degree of potentiation in CAP-evoked currents.  Thus, 
these data suggest that other molecular mechanisms may be involved in the potentiated 
phenomenon. 
 
2.3.3 Inhibition of PKC  activity revealed two types of responses following repetitive 
activation of TRPV1 receptors  
 The resulting potentiation of CAP-evoked currents in all neurons recorded under Ba-
ECF, which was similar to the biphasic response though smaller in amplitude, suggested that 
other factors may be involved in the generation of the potentiation response.  The gradual 
potentiation of CAP-evoked currents observed in the present study is similar to that previously 
reported from studies where PKC activity was pharmacologically manipulated. An increase of 
PKC activity sensitized TRPV1 channels, causing a gradual increase in the channel‟s membrane 
current following repetitive CAP-induced activation (Prekumar & Ahern, 2000; Vellani et al., 
2001; Bhave et al., 2003).  However, this effect was never reported under control conditions.  It 
is possible that PKC may be involved in the biphasic response observed in the present study.  To 
examine the influence of PKC activity on the biphasic response in neurons, I first examined the  
 
B 
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Figure 2-3.  Inhibition of PKCβ activity appeared to prevent the potentiated phenomenon in 
the biphasic response and greatly enhanced desensitization in the monophasic response. (A) 
Whole-cell current traces were obtained from DRG neurons exposed to an intracellular solution 
containing the PKCβ  inhibitor, LY333531 (50 nM), and exposed to repeated applications of 
CAP (1 s, 15 s).  Top row, represents whole-cell current traces from cells recorded in control 
conditions displaying the monophasic (left) or biphasic (right) response.  Bottom row, represents 
whole-cell current traces from cells exposed to LY333531 displaying characteristics of the 
monophasic response (left) or the biphasic response (right). (B) Bar graph summaries 
mean SEM peak current density for the initial CAP-evoked current in neurons displaying the 
monophasic and biphasic response in control and LY333531 conditions. * indicates statistical 
significance between conditions at a level of p<0.05. *** indicates statistical significance 
between conditions at a level of p<0.001. (C) The bar graph is a summary of the distribution of 
the monophasic-like response (black) and the biphasic-like response (white) from the sampled 
population of neurons treated with LY333531. 
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influence of the PKC beta isoform (PKC ), a classic PKC isoform that hasbeen shown to play a 
role in a number of diabetic complications (Geraldes & King, 2010), particularly in diabetic 
hyperalgesia (Kim et al., 2003; Tahara et al., 2006). 
DRG neurons were exposed intracellularly to the PKC  inhibitor, LY333531 (50 nM), 
through the patch-pipette   Once whole-cell configuration was achieved, the inhibitor was 
allowed to diffuse into the cell for 5 minutes prior to recording currents.  Following a series of 
brief CAP applications (1 s, 15 s), whole-cell currents exhibited two types of responses that 
displayed distinctive initial peak current amplitudes (I1) that allowed identification of the  
monophasic and biphasic responses (Fig. 2-3A and B).  The first type was consistent with the 
monophasic response (“monophasic-like”), where the first application of CAP caused a large 
inward current that underwent tachyphylactic desensitization (Fig. 2-3A, bottom row, left),  
although, the desensitization rate seemed to be faster and more robust than that observed in the 
monophasic response under control conditions (Fig. 2-3A, top row). The second response 
(“biphasic-like”) displayed a small inward current that desensitized following successive 
applications of CAP.  Interestingly, when the distribution of the responses in neurons treated 
with LY333531 were examined, 68% of neurons displayed the monophasic-like response, while 
32% displayed the biphasic-like response, similar to the distribution of monophasic and biphasic 
neurons in the control condition (Fig. 2-3C). 
To further evaluate the influence of LY333531 on TRPV1 currents, the degree of 
desensitization and potentiation were examined (Table 2-2).  Interestingly, the degree of 
desensitization, measured as the percentage of I15 relative to Imax, for the monophasic-like 
response was nearly two-folds greater with LY333531, displaying a 76.0±3.41% decrease in 
maximal current response, while only a 44.1±5.25% decrease in maximal current response was 
revealed for the control condition (Fig. 2-4A).  Conversely, the biphasic-like response for 
neurons treated with LY333531 displayed a similar degree of desensitization (32.0±10.8%) that 
was not significantly different from the biphasic response in control (39.0±4.0%, p=0.8765), 
suggesting that the desensitization for the biphasic-like response was unaffected by the PKC  
inhibitor. To evaluate the influence of LY333531 on the potentiation phenomenon, the degree of 
potentiation measured as the percent increase from I1 to Imax was evaluated between biphasic 
neurons from the control and LY333531 treated conditions.   It was revealed that LY333531 
prevented the potentiation that occurred in control neurons that displayed the biphasic response, 
B 
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Table 2-2 Quantitative assessment and comparison of current traces between monophasic 
and biphasic responses from DRG neurons under control and LY333531 conditions. 
  Control  LY333531  
Parameters  Monophasic  
(n=10)  
Biphasic 
(n=7)  
Monophasic  
(n=11)  
Biphasic  
(n=5)  
Peak current 
density 
(pA/pF)  
I1  24.47±4.46  13.25±1.87*  35.88±3.67  8.46±1.59 ***
 
 
Imax  22.68±5.41  28.44±4.56  35.88±3.67  8.89±1.53***  
Percentage of 
desensitization 
(%)  
Imax/I15  44.1±5.25 39.0±4.0 76.0±3.41
$$$
 32.0±10.8  
Percentage of 
potentiation 
(%)  
Imax/I1   50.4±5.65  7.47±5.51
$
 
 
* indicates a significant difference between behaviours within treatment conditions at a level of 
p<0.05 
***indicates a significant difference between behaviours within treatment conditions at a level of 
p<0.001. 
$
 indicates a significant difference in  the behaviour between treatment conditions at a level of 
p<0.05 
$$$
 indicates a significant difference in the behaviour between treatment conditions at a level of 
p<0.001. 
 
 
 
 
27 
 
 
 
Figure 2-4.   Inhibition of PKCβ activity altered the sensitivity of TRPV1 receptors 
influencing the monophasic and biphasic response.   Bar graphs  (A and B) summarizes the 
mean SEM percentage of desensitization for neurons displaying the monophasic or biphasic 
response in control (black) and LY333531 (white) conditions and the percentage of potentiation 
for neurons responding in a biphasic-like manner when treated with LY33531 and in the control 
condition. * indicates a statistical significance between conditions at a level of p<0.05.
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revealing a 7.47±5.51% potentiation in current generated relative to 50.4±5.65% potentiation 
observed in control neurons (Fig. 2-4B).  Collectively, these findings suggest that inhibition of 
PKCβ activity greatly affected the response of TRPV1 receptors upon CAP activation, 
influencing both the desensitization and potentiation characteristic of the monophasic and 
biphasic responses. 
 
2.3.4 Adult DRG neurons also display the monophasic and biphasic responses 
During maturation, differentiation into peptidergic and nonpeptidergic neurons is highly 
dependent on growth factors.  In addition, it has been recently shown that TRPV1 expression is 
down-regulated in nonpeptidergic DRG neurons, while peptidergic DRG neurons maintain the 
receptor expression, suggesting that this subpopulation of neurons has a greater role in pain 
processing (Cavanaugh et al., 2011).  To determine the relevance of my findings in neonates to 
adult mice, I investigated whether TRPV1 receptors expressed in DRG neurons from one-month 
old adult mice also exhibited the monophasic and biphasic responses.  To do this, I used 
enhanced GFP under the control of the CGRP promoter in transgenic CD1 (tgCGRP-eGFP) 
mice, to generate DRG cultures allowing selective identification of CGRP+ peptidergic neurons.  
Similar to neonatal DRG neurons, whole-cell current traces from adult DRG neurons displayed 
either a monophasic or biphasic response (Fig. 2-5A).  With the 50% threshold criterion, there 
was a greater distribution of cells displaying the monophasic response (nearly 75%) compared to 
those displaying the biphasic response (~25%, Fig. 2-5B).  Collectively, these findings support 
that the types of responses observed are an inherent property of TRPV1 channels that exists 
postnatal and in mature mouse DRG neurons. 
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Figure 2-5.  Adult DRG neurons also displayed monophasic and biphasic responses in 
TRPV1 activity. (A) In control in vitro conditions, whole-cell current traces from adult DRG 
neurons also exhibited monophasic and biphasic responses from repeated application of 
capsaicin. (B) Bar graph summarizes the distribution of monophasic (black) and biphasic 
(white). 
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2.4 Discussion 
In this study, I characterized the responses of lumbar DRG neurons to repetitive CAP 
applications, which are mediated by the activation of TRPV1 receptors.  The successive 
application of CAP evoked currents that underwent a run-down or tachyphylactic desensitization 
due to repeated exposure to the agonist.  Tachyphylaxis is known to be mediated by calcium 
entry and the protein phosphatase calcineurin (Petersen et al., 1996; Docherty et al., 1997; 
Koplas et al., 1997).  It was therefore unexpected to find that successive applications of CAP 
elicited two distinct responses in cultured DRG neurons: a „monophasic response‟ characterized 
by the tachyphylactic desensitization of the original peak current and a „biphasic response‟ 
characterized by the gradual potentiation of the CAP-evoked currents followed by tachyphylactic 
desensitization.   
 
2.4.1 Effect of calcium on the monophasic and biphasic responses 
The tachyphylaxis observed in both responses suggested that calcium entry was critical in 
initiating the desensitization of the channel upon repeated exposure to CAP (Docherty et al., 
1996; Koplas et al., 1997).  In fact, when calcium was substituted by barium in the extracellular 
solution, none of the neurons exhibited desensitization; rather, CAP-evoked currents were 
smaller in amplitude and displayed a gradual potentiation following successive applications of 
CAP.  The findings from the barium experiment revealed three interesting characteristics of the 
TRPV1-mediated currents in DRG neurons: 1) the current potentiation of TRPV1 was 
independent of extracellular calcium, because it still occurred in Ba-ECF solutions; 2) the 
temporal progression of current potentiation was dependent on calcium or calcium-related 
signalling, since a greater number of CAP applications were required to reach maximal current 
amplitude in Ba-ECF; and interestingly, 3) initiation of tachyphylaxis was calcium-dependent, 
since it did not occur in Ba-ECF as was shown previously (Koplas et al., 1997; Docherty et al., 
1997; Mohapatra & Nau, 2005). 
From this study, I cannot rule out a possible role of intracellular calcium in TRPV1 
activity in response to repetitive CAP applications.  For instance, it was previously suggested 
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(Koplas et al., 1997) that the rise in intracellular calcium to a threshold level may facilitate 
calcium entry-induced desensitization of TRPV1 receptors.  In future experiments, we plan to 
monitor and manipulate the level of intracellular calcium during repetitive CAP applications to 
test whether intracellular calcium affects the responses reported here.  
Similarly, it is possible that the phosphatase calcineurin, which is activated by calcium 
and dephosphorylates TRPV1 receptors, leads to tachyphylactic desensitization (Mohapatra & 
Nau, 2005; Por et al., 2010).  The inability to induce desensitization in TRPV1-mediated currents 
in the barium experiment could be attributed to the lack of calcium entry and the inability to 
activate calcineurin.  However, additional experiments will need to delineate the role of 
intracellular calcium and calcineurin in regulating the monophasic and biphasic responses of the 
TRPV1 receptor.  
 
2.4.2 Possible role of calcium-dependent signalling in the responses of DRG neurons to 
repetitive CAP applications 
One should also consider the possibility that other mechanisms such as phosphorylation 
of the TRPV1 receptor by calcium-dependent PKC (Prekumar & Ahern, 2000; Velanni et al., 
2001; Bhave et al., 2003), or CaMKII and ERK signalling (Zhang et al., 2010), could be 
involved in the gradual potentiation observed in the present study that were independent of 
pronociceptive effects influenced by inflammation or neurotrophic factors.  Certainly, these 
endogenous activators can influence and regulate TRPV1 activity under physiological 
conditions.  Under experimental conditions, activation of PKC in sensory neurons has been 
shown to increase the open probability of the TRPV1 receptor (Vellani et al., 2001).  The fact 
that a lack of calcium in the Ba-ECF experiments led to potentiation in all the studied neurons, 
suggests that a calcium-regulated signalling protein may be responsible for the occurrence of the 
monophasic and biphasic responses.  Therefore, I asked whether PKC may be responsible for the 
responses observed following repetitive CAP applications.  I used the PKC  inhibitor 
LY333531, because this PKC isoform is regulated by calcium and it was previously linked to 
attenuating diabetic hyperalgesia in STZ-induced diabetic rats (Kim et al., 2003).  Neurons 
treated with LY333531 also displayed two types of responses that resembled the monophasic and 
biphasic responses, and were classified as monophasic-like and biphasic-like, respectively.  The 
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monophasic-like response displayed a large inward current that desensitized by tachyphylaxis; 
however, the run-down was more robust than in the control condition.  The mechanism for this 
robust effect may be attributed to the ongoing competition between kinases and phosphatases in 
regulating the TRPV1 channels.  Reducing kinase activity may increase the probability of 
dephosphorylation of the TRPV1 receptor, and subsequently reduced sensitivity when exposed to 
the agonist.  The biphasic-like response, however, displayed smaller currents that desensitized 
following a series of CAP applications.  This suggests that phosphorylation of TRPV1 by PKC  
mediates the potentiation phenomenon in the biphasic response upon repeated applications of 
CAP.  In addition, desensitization of the biphasic-like response could be related to similar 
mechanisms mediating the robust desensitization in the monophasic-like response.  Conversely, 
it has been reported that PKC can endogenously activate TRPV1-mediated current in the absence 
of agonist application and similarly produce sensitization of membrane current upon repeated 
exposure to the PKC activator (Prekumar & Ahern, 2000). The findings of the present study 
would agree that the responses observed in TRPV1 activity was dependent on CAP-induced 
activation of the receptor as previously described (Vellani et al., 2001; Bhave et al., 2003) but the 
difference in monophasic and biphasic response may be influenced by the phosphorylated or 
dephosphorylated state of TRPV1. 
While CAMKII and ERK signalling have demonstrated a time-dependent potentiation in 
TRPV1-mediated currents of at least 40 minutes between CAP applications (Zhang et al., 2010), 
and may be involved in the re-sensitization of the receptor (Jung et al., 2004), it unlikely that the 
potentiation observed in the present study was due to CAMKII-induced recovery of TRPV1 
desensitization. The CAP protocol that I used to evoke TRPV1-mediated currents was shorter 
than is required to activate that pathway.  Nevertheless, the present study demonstrated that 
under physiological conditions, repeated activation of TRPV1 by CAP can elicit two responses: a 
monophasic or biphasic response, which may be dependent on the phosphorylated or 
dephosphorylated state of the receptor prior to CAP application.   
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2.5 Conclusion 
In summary, I have identified and characterized two types of responses in TRPV1-
mediated currents: a monophasic and biphasic response, following a series of CAP applications 
in control in vitro conditions.   To my knowledge, the biphasic response has not been identified 
in the literature of TRPV1 under control condition.  In the absence of external calcium, all cells 
exhibited a gradual potentiation in TRPV1-mediated currents, similar to the potentiation 
observed in the biphasic response for cells recorded in the presence of external calcium. It should 
be considered that endogenous proteins (i.e. PKC, calcineurin, CAMKII) or intracellular calcium 
in DRG neurons can affect the sensitivity of TRPV1 receptors under control conditions and 
certainly reflected the two responses observed in this study. 
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CHAPTER 3 
 
 
EFFECTS OF HIGH GLUCOSE ON P2X AND TRPV1 RECEPTORS IN MOUSE 
SENSORY NEURONS 
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3.1 Introduction 
Diabetic sensory neuropathy (DSN) is associated with functional and morphological 
changes to the sensory nerves leading to reduction of nerve conduction velocity and the distal 
dying-back of axons (Polydefkis et al., 2004; Malik et al., 2005).  Many patients with DSN 
display sensory abnormalities, including chronic pain or numbness in the distal limbs.  In recent 
years, the idea has emerged that the dysregulation of glucose levels activate multiple distinct 
metabolic pathways leading to a singular end result: oxidative stress (reviewed by Brownlee, 
2001; Vincent, et al., 2011).  The increase in metabolic flux has been associated with dynamic 
changes in the mitochondrial morphology contributing to the overproduction of reactive oxygen 
species (ROS) in sensory neurons of the dorsal root ganglion (DRG, Russell et al., 2002; Vincent 
et al., 2002 & 2005a; Yu, Robotham & Yoon, 2006).  However, it remains poorly understood 
what cellular and molecular mechanisms are influenced by ROS that contribute to the structural 
and functional changes in sensory neurons during diabetes.   
Sensory DRG neurons are comprised of a heterogeneous population of neurotransmitter 
receptors.  The purinergic (P2X) receptors and transient receptor potential 1 (TRPV1) channels 
have been identified as main players in sensory function and, in particular, of nociception (Chen 
et al., 1995; Caterina et al., 1997).  P2X receptors are membrane ion channels activated by the 
binding of extracellular adenosine triphosphate (ATP, Grubb & Evans, 1999).  Seven different 
subclasses have been reported (P2X1-7; North, 2002).   In DRG neurons, a high proportion of 
mRNA transcript for the homodimeric P2X3 receptor are expressed, followed by P2X2 and 
heterodimeric P2X2/3 receptors (Chen et al., 1995; Lewis et al., 1995; Stebbing et al., 1998).  
The TRPV1 receptor is a polymodal detector activated by a number of stimuli: capsaicin, protons 
(pH), heat (>42°C), and arachidonic acid (Caterina et al., 1997).  Although these receptors have 
been extensively studied with regards to pain processing, their role during hyperglycemic 
conditions remain poorly understood. 
 The present study investigated the role of high glucose-induced oxidative stress on P2X 
and TRPV1 receptors expressed on lumbar sensory neurons from neonatal mice in culture.  In 
these experiments, an electrophysiological approach was used to examine the function of P2X 
and TRPV1 receptors exposed to repetitive agonist applications.  In a series of ATP applications, 
no changes in the behavior of P2X-mediated currents were observed in neurons treated with high 
glucose relative to control.  As denoted in Chapter 2, repeated applications of CAP evoked two 
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forms of responses in TRPV1-mediated currents: monophasic and biphasic responses (Chapter 
2).  In the present study, it was observed that these responses persisted following high glucose 
treatment.  However, high glucose treatment caused an enhancement of TRPV1-medated 
currents in both type of responses, which was largely dependent on calcium entry.  Because 
experiments with a ROS-sensitive dye revealed that high glucose-induced oxidative stress in 
DRG neurons, I next used an antioxidant mixture, which successfully reversed the high glucose-
induced enhancement of currents.  Lastly, I compared this effect of high glucose on TRPV1-
mediated currents in DRG neurons from neonates and adult mice and found that although similar 
behaviours of TRPV1 currents were observed, the effects of high glucose displayed a differential 
degree of potentiation in adult DRG neurons. 
 
3.2 Methods 
 
3.2.1 Cell cultures  
All experiments were approved by the University of Saskatchewan’s Animal Research 
Ethics Board, and adhered to the Canadian Council on Animal Care guidelines for humane 
animal use.   Primary DRG cultures for neonatal C57BL/6 mice between postnatal day 1 to 3 
(P1-P3) were used for the preparation of the dissociated DRG cultures.  The methods used to 
dissociate the neurons were similar to the protocol used to dissociate superior cervical ganglion 
neurons (McFarlane & Cooper, 1992; Campanucci et al., 2008).  Briefly, mice were euthanized 
by cervical transection in a sterile environment.  Lumbar (L1 to L5) DRGs from the spinal cord 
were collected into a Petri dish with serum-containing media (L15 supplemented with vitamins, 
cofactors, penicillin-streptomycin and 5 mM glucose, and 10% horse serum).  Small iris scissors 
were used to trim the remaining nerve roots from the ganglia.  Once cleaned, the ganglia were 
submerged in an enzymatic solution (0.1% trypsin; Worthington, Freehold, NJ, USA) buffered 
with 1 M of HEPES (pH 7.4), and incubated at 37°C for 30- 45 min in the water bath for 
enzymatic dissociation of ganglia. 
Next, DRGs were mechanically dissociated by using a fire-polished pipette.  The 
dissociated neurons were rinsed twice with serum-containing media to inactivate trypsin. The 
resulting cell suspension was transferred to growth media consisting of L-15 supplemented with 
vitamins, cofactors, penicillin-streptomycin, 5% rat serum, 7S Nerve Growth Factor (10 ng/ ml) 
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and 5 mM of glucose.  The neurons were plated on laminin-coated coverslips attached to 
modified 35 mm tissue culture dishes.  Cells were maintained at 37°C in a 95% air and 5% CO2 
environment and fed every 3-4 days with growth media.  To eliminate non-neuronal cells, 
cultures were treated with cytosine arabinoside (10 M; Sigma, St. Louis, MO, USA) from day 1 
to day 3.   Cells were allowed to recover from stress and axotomy for one week prior to any 
treatment or experimental procedure.   Cultured neurons were maintained in medium containing 
either 5 mM glucose (control) or switched to 25 mM glucose (high glucose), for 1 week.  Two 
weeks following the day of culture, cells were subjected to electrophysiological experiments. 
The method used to isolate of DRG neurons from adult transgenic CGRP- eGFP CD1 
mice were similar to the protocol used in this study with minor modification based on the 
protocol used by Burkey et al. (2004).  Briefly, dissected and cleaned lumbar DRGs were 
incubated at 37 °C in 0.1% collagenase (Worthington type 2, Calbiochem, San Diego, CA, USA) 
for 30 minutes and then 0.1% trypsin for an additional 30 minutes. After titration, the dissociated 
neurons were rinsed with Dulbecco’s modified eagle medium (DMEM, Gibco, Carlsbad, CA, 
USA) containing 10% horse serum, followed by resuspension in growth media containing 
DMEM supplemented with vitamins, cofactors, penicillin-streptomycin, 5% rat serum, 7S Nerve 
Growth Factor (10 ng/ ml) and 5 mM of glucose.  Maintenance of cultured adult neurons was as 
indicated for neonatal neurons. 
 
3.2.2 ROS Levels and Oxidative stress 
 To measure cytoplasmic ROS levels, I used the redox- sensitive dye CM-H2DCFDA 
(Molecular Probes, Burlington, Ontario, Canada), an acetoxymethyl (AM) ester.  Cultures were 
incubated for one hour at 37°C with medium containing CM-H2DCFDA (10µM) and 
subsequently washed five times with standard extracellular solution (see below).  The cultures 
were then placed on the stage of an inverted epifluorescent microscope (Axiovert 200) and 
viewed through 40X oil-immersion objective (Zeiss) at room temperature.  To obtain fluorescent 
images, I excited the cultures with 450 nm wavelength.  To quantify the fluorescent intensity, 
the difference in intensity of the region of interest (neuronal cell body, excluding the nucleus) to 
the background was taken.  
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3.2.3 Electrophysiology  
CAP-evoked current were recorded using the whole-cell patch-clamp technique (Hamill 
et al., 1981).  Patch pipettes were made from borosilicate glass (WPI, Sarasota, FL, USA)  
using a vertical puller (PC 10; Narishige Scientific Instrument Lab., Tokyo, Japan) and were fire-
polished using a microforge (MF 900; Narishige). Micropipettes had a resistance of 5-10 M  
when filled with intracellular recording solution, and formed gigaseals of 1-8 G .  Recording 
electrodes were filled with the following solution (in mM): 60 KAc, 70 KF, 5 NaCl, 1 MgCl2, 1 
CaCl2, 2 MgATP, 10 EGTA, and 10 HEPES, and pH was adjusted to 7.2 with KOH. For 
experiments using antioxidants, 500 µM of the antioxidant -lipoic acid and 1000 U/mL of 
catalase was prepared fresh on the day of the experiment and dissolved in intracellular solution.  
Intracellular solution dialysis of 15 minutes was necessary to reduce cytoplasmic ROS levels as 
described previously by Campanucci et al. (2010), prior to the start of the experiment.  
 Junction potentials were cancelled at the beginning of the experiment. The external 
solution contained (in mM): 140 NaCl, 5.4 KCl, 0.33 NaH2PO4, 0.44 KH2PO4, 1 MgCl2, 1 
CaCl2, 10 HEPES, and 5 glucose, and pH was adjusted to 7.4 with NaOH.   For barium 
experiments, 1-2 mM of BaCl2 was used in place of CaCl2 in the external solution. Whole-cell 
currents or membrane potentials were recorded at room temperature with the aid of an Axopatch 
200B amplifier (Axon Instruments Inc., Union City, CA, USA) equipped with a 1 G  headstage 
feedback resistor. and sampled at 1kHz and 5 kHz for ATP and CAP experiments, respectively, 
with a Digidata 1440A.  Voltage clamp protocols, data acquisition and analysis were performed 
using pCLAMP 10 software (Axon Instruments) and Origin 7 (OriginLab Coorporation, 
Northampton, MA, USA).  Once the whole-cell configuration was achieved, cells were allowed 
to stabilize for 5 min before recording.  Using a fast-step perfusion system, neurons were 
exposed to control or agonist solutions [CAP (5 µM) or ATP (100 µM)] at a rate of 1 mL/min.  
Tetrotodoxin (TTX, 1 μM) was added to both control and CAP solutions to block voltage-gated 
sodium channels.   
 
3.2.4 Statistics 
To compare mean fluorescent intensities, I used  the unpaired student’s t- test. For current 
ratios, integrated area and percentages, the Mann Whitney nonparametric test was used.  To 
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compare proportion of neurons in each condition, I used the Fisher’s exact test (P1-P2).  For 
comparison among multiple treatments, one-way ANOVA supplemented with Tukey’s post hoc 
analysis was used.  
 
3.3 Results 
 
3.3.1 Increased oxidative stress in DRG neurons exposed to high glucose 
 Previous studies reported that exposure of DRG neurons to high glucose causes the 
accumulation of cytoplasmic ROS and the induction of oxidative stress (Russell et al., 2002; 
Vincent et al., 2002 & 2005a).  To test whether high glucose in our hands induced oxidative 
stress, I exposed cultured DRG neurons to high glucose (25 mM) for 1 week and I monitored the 
cytoplasmic ROS levels with the ROS sensitive dye CM-H2DCFDA.  This experiment (Fig. 3-1) 
resulted in a significant two-fold increase in the mean pixel intensity in neurons exposed to high 
glucose (n=102) versus those in control conditions (5 mM of glucose; n=163).   
 
3.3.2 Effects of high glucose on P2X-mediated currents in DRG neurons 
   Next, I examined the influence of high glucose (1 week) on the function of P2X 
receptors expressed in DRG neurons. To examine this, whole-cell currents were recorded 
following a series of ATP applications (100 µM, 1 s at 3 min intervals) on small to medium 
diameter (15-25 pF) DRG neurons.  Applications of ATP predominantly evoked currents with 
fast-inactivating kinetics that resembled those carried by homodimeric P2X3 receptors, as 
described by Grubb & Evans (1999),  in high glucose (Fig. 3-2A).  To compare the influx of 
current over repetitive ATP applications in control and high glucose conditions, I examined the 
change in peak current (measured as a ratio of the 5
th
 ATP- evoked current to the first in the 
series), and the integrated area of the 5
th
 ATP-evoked current in the series.  These comparisons 
did not show a significant change in ATP-evoked currents in control versus high glucose 
conditions (Fig. 3-2B and C).  Collectively, these findings suggest that P2X-mediated currents in 
small to medium size lumbar DRG neurons were not affected by high glucose. 
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Figure 3-1.   DRG neurons exposed to high glucose for at least 7 days show elevated ROS 
levels.  (A) DIC images of cultured DRG neurons in control (5 mM, left column) and high 
glucose (HG, 25 mM) conditions.  (B) The bar graph summarizes mean  SEM pixel intensity for 
ROS. *** indicates a statistical significance between conditions at p<0.001.  Left, example of 
fluorescent images of DRG neurons from a different set of cultures that were treated with the 
ROS sensitive dye, CM-H2DCFDA, in control (shown by the yellow arrows) and HG conditions 
to examine the differences in cytoplasmic ROS levels.   
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Figure 3-2.  One week of high glucose had no perceived effect on ATP-evoked currents in 
DRG neurons.  (A) A series of ATP application (100 µM, 1 s) every 3 minutes evoked a current 
response resembling P2X3 kinetics, which was fast-inactivating in control (top row) and high 
glucose (HG, bottom row) neurons in whole-cell voltage clamp mode.  (B) and (C), The mean  
SEM current ratio of the 5
th
 ATP-evoked current to the 1
st
 ATP-evoked current and the mean  
SEM integrated current area of the 5
th
 ATP-evoked current revealed no significant differences 
between conditions using the Mann-Whitney nonparametric test. 
 
 
 
 
 
 
 
ATP (100 M) 
ATP (100 M) 
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3.3.3 Effects of high glucose on TRPV1-mediated currents in DRG neurons 
I have previously reported that repetitive application of capsaicin (CAP, 5 µM, at 15 s 
intervals) elicited two types of responses in TRPV1-mediated currents: monophasic and biphasic 
responses (Chapter 2).  Using the same protocol to apply CAP, I next examined the effects of 
high glucose on TRPV1-mediated currents using the whole-cell patch clamp technique.  In these 
experiments, I observed the monophasic and biphasic responses in both experimental conditions 
(Fig. 3-3A).  As described in Chapter 2, to distinguish cells exhibiting the biphasic response from 
monophasic response, I used a threshold criterion of a 50% increase in peak current amplitude 
from the maximum current amplitude (Imax) to the 1
st
 (I1) in the series.  Based on this criterion, 
the distribution of the monophasic and biphasic responses in the high glucose condition was not 
significantly different from the control condition (Fig. 3-3B).   
As described in Chapter 2, measurements of the peak current density of I1indicated that 
the monophasic response was two-fold greater than I1 for the biphasic response (Table 3-1).  This 
effect persisted under high glucose conditions.  However, it was observed that in high glucose 
the currents appeared enhanced (Fig. 3-3C).  To quantify this potentiation, I examined the peak 
current density of Imax between conditions (note: in the monophasic response, Imax is I1).  
Statistical analysis revealed a significant increase in peak current density of Imax in high glucose 
versus control for both responses (Fig. 3-4A).   Interestingly, I noticed that under the high 
glucose condition, the duration of the current increased over a single CAP application.  
Therefore, to quantify this observed effect, I examined the integrated area of Imax.  It was 
revealed that there was a significant increase in the integrated area of Imax in high glucose versus 
control conditions, in both the monophasic and biphasic responses (p<0.05, Fig. 3-4B).  This 
suggested that in high glucose, the amount of current in both the monophasic and biphasic 
responses was enhanced.  To examine if this enhancement in CAP-evoked currents had an affect 
on the parameters of the responses in high glucose, I compared the percentage of Imax to I15 to 
quantify the degree of tachyphylactic desensitization or I1 to Imax in the biphasic response to 
quantify the degree of potentiation (Fig. 3-4C and D, respectively).  Interestingly, 
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Figure 3-3. CAP-evoked currents show two distinct types of responses in both control and 
high glucose conditions. (A)Whole-cell currents in voltage clamp mode were obtained from a 
series of CAP applications (5µM, 1 s) at short intervals of 15 s  revealing two behavioural 
responses in TRPV1 currents  in control (top row) and high glucose (HG, bottom row) 
conditions. The monophasic response displayed desensitization in TRPV1- mediated currents 
(left column), while the biphasic response displayed a gradual potentiation followed by 
desensitization in TRPV1-mediated currents (right column) in both conditions.  Superimposition 
of these current traces is represented following every 3 applications of CAP. (B) The bar graph 
summarizes the percentage of neurons exhibiting the monophasic (black) or biphasic (white) 
response in the sampled population from control and HG conditions.  (C) The difference in the 
current generated between conditions is depicted by the overlap of Imax current traces from 
control (black) and HG (red) in the monophasic (left) and biphasic (right) responses. 
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Table 3-1. Quantitative comparison between monophasic and biphasic in control and high 
glucose conditions. 
 
  Control  HG  
Parameters  Monophasic 
(n=10)  
Biphasic 
(n=7)  
Monophasic 
(n=18)  
Biphasic  
(n=8)  
Peak current 
density 
(pA/pF)  
I
1 
 24.47±4.46  13.25±1.87*  34.48±4.72  17.85±2.63 **  
I
max 
 22.68±5.41  28.44±4.56 40.29±5.08$ 47.24±6.38$  
Integrated 
area (pC)  
I
1
 0.40x10
7
±0.11
x10
7
  
0.22x10
7
±0.40x
10
7
  
0.91x10
7
±0.22
x10
7
  
0.39x10
7
±0.07
x10
7
  
I
max
 0.53x10
7
±0.11
x10
7
  
0.66x10
7
±0.18x
10
7
  
1.17x10
7
±0.22
x10
7
 $ 
1.52x10
7
±0.34
x10
7
 $ 
Percentage of 
desensitization 
(%)  
Imax/I15  44.1±5.25 39.0±4.0 46.80±5.89  49.91±7.86  
Percentage of 
potentiation 
(%)  
Imax/I1   50.4±5.65  60.63±4.27  
 
* indicates a significant difference between responses within treatment conditions at a level of 
p<0.05 
$ indicates a significant difference between responses comparing treatment conditions at a level 
of p<0.05 
** indicates a significant difference between responses within treatment conditions at a level of 
p<0.01. 
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Figure 3-4.  High glucose enhanced TRPV1-mediated currents but had no perceived 
influence on the activity of the TRPV1 receptor.  The bar graphs summarizes the mean ± SEM 
peak current density (A) and integrated area (B) of Imax CAP-evoked current in neurons 
exhibiting the monophasic or biphasic response under control (black) and HG conditions (white).  
Neurons exposed to HG regardless of the type of response show a significant increase in peak 
current density and integrated current area at a level of p<0.05, *.  Bar graphs (C and D) 
summaries the mean± SEM of the degree of desensitization (measured as the percentage of Imax 
relative to I15) and the degree of potentiation (measured as the percentage of I1 relative to Imax) in 
control and HG conditions. Statistical analysis using Mann-Whitney nonparametric test revealed 
no significant differences between conditions. 
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this comparison showed no significant difference between conditions, suggesting that the 
mechanisms underlying  the enhancement in the TRPV1-mediated currents under high glucose 
did not affect the mechanisms of desensitization and potentiation characteristic of the 
monophasic and biphasic responses. 
 
3.3.4 The enhancement of the CAP-evoked current under high glucose is calcium-
dependent 
Next, I asked whether the enhancement in CAP-evoked currents was calcium dependent.  
Previous studies reported abnormal calcium homeostasis in sensory neurons from STZ-induced 
diabetic animals (Huang et al., 2002; Fernyhough & Calcutt, 2010).  Whether Ca
2+
 carried by 
TRPV1 receptors contributed to this homeostatic imbalance during hyperglycemia remains to be 
determined. Therefore, I conducted an experiment in which Ca
2+
in the extracellular fluid was 
substituted with the divalent cation barium (Ba
2+
, Ba-ECF) to test the role of Ca
2+
 on CAP-
evoked currents during high glucose. As previously shown in Chapter 2, all neurons displayed 
smaller currents that potentiated in Ba-ECF (Fig. 3-5A, right column).  This phenomenon 
persisted in neurons in high glucose (n=14).  Interestingly, the enhancement of CAP-evoked 
currents observed in high glucose when recording in Ca-ECF (Fig. 3-5A, left column) was absent 
in Ba-ECF.  This was based on the comparison of the degree of potentiation in the biphasic 
response between control and HG conditions (Fig. 3-5B and C).  This suggested that the 
enhancement of Imax in the biphasic response during high glucose was calcium dependent.  The 
lack of desensitization in neurons recorded in Ba-ECF supports previous work demonstrating 
that the influx of calcium was necessary to desensitize TRPV1 receptors (Docherty et al, 1996; 
Koplas, 1997).   
 
3.3.5 Antioxidant cocktail reversed the enhancement of CAP-evoked currents under high 
glucose 
Since the central hypothesis of the present study that oxidative stress is the key mediator 
in the enhancement of CAP-evoked currents caused by high glucose, I investigated whether the 
enhancement of TRPV1-mediated current in high glucose could be prevented by reducing  
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Figure 3-5. Effects of high glucose on CAP-evoked current is calcium dependent.  (A) 
Barium, a divalent cation, was used to examine calcium dependency of TRPV1 currents under 
high glucose conditions.  Whole- cell current traces from neurons in control (top row) and HG 
(bottom row) recorded in Ba-ECF revealed an initial potentiation (left column) that resembled 
the potentiation in the biphasic response for neurons recorded in Ca-ECF (right column).  
However, subsequent applications of CAP evoked current amplitudes that remained stable in 
amplitude shown at the 20
th
 CAP-evoked current (I20), which contrasted the desensitization 
observed in neurons recorded in Ca-ECF at  I20. (B) Superimposition of Imax CAP-evoked 
currents for control (left) and HG (right) neurons recorded in Ca-ECF (black and red current 
traces) compared to neurons recorded in Ba-ECF (green and orange current traces). (C) The 
scatter plot summaries the mean± SEM peak current density as a function of CAP applications 
for control (5mM) and HG (25mM) neurons recorded in Ca-ECF and Ba-ECF.
 
 
 
 
B 
 
B 
 
CAP application 
CAP (5 M) CAP (5 M) 
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cytoplasmic ROS levels.  An experiment was performed to determine whether an antioxidant 
cocktail (500µM of α-lipoic acid and 1000 U/mL of catalase, ALA), loaded into the recording 
electrode, would reverse the enhancement of TRPV1-mediated current observed in neurons 
under the high glucose condition.  Interestingly, antioxidant-treated neurons recorded in whole-
cell patch clamp mode exhibited an altered response that was not characteristic of the 
monophasic or biphasic response.  CAP-evoked current recorded in the presence of antioxidant 
cocktail did not potentiate or desensitize. Rather, whole-cell current traces displayed an initial 
large inward current followed by stable CAP-evoked currents that were usually half the size of 
the initial current (Fig. 3-6A).  
 To evaluate this effect, I examined the peak current amplitude and integrated area of the 
6
th
 CAP-evoked current in the series.  The mean peak current density of the 6
th
 CAP-evoked 
current in control+ ALA was significantly decreased compared to control neurons.  Remarkably, 
when neurons were exposed to HG+ ALA, the enhancement of I6 was prevented and comparable 
to control conditions (Fig. 3-6B).  Collectively, the data gathered from this experiment suggested 
that the enhancement of TRPV1-mediated currents under the high glucose condition can be 
reversed by reducing cytoplasmic ROS through intracellular application of antioxidants.  
However, since cytoplasmic redox state played a role in the type of responses (i.e. monophasic or 
biphasic) observed in DRG neurons, it suggests that these responses need to be further explored. 
 
3.3.6 Adult DRG neurons also show enhancement of CAP- evoked currents under high 
glucose 
During maturation, differentiation into peptidergic and nonpeptidergic neurons is highly 
dependent on growth factors.  In addition, it has been recently shown that TRPV1 expression is 
down-regulated in nonpeptidergic DRG neurons, while peptidergic DRG neurons maintain 
receptor expression, suggesting that this subpopulation of neurons has a greater role in pain 
processing (Cavanaugh et al., 2011).  To determine the relevance of my findings, I investigated 
whether TRPV1 receptors expressed in DRG neurons from one-month old adult mice also 
exhibited the enhancement of the CAP-evoked currents as a result of elevation in ROS by high 
glucose.  To do this, I used enhanced GFP under the control of the CGRP promoter in transgenic 
CD1 (tgCGRP-eGFP) mice, to generate adult DRG cultures allowing selective identification of 
CGRP+ peptidergic neurons.  Similar to neonates and as described in Chapter 2, whole-cell  
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Figure 3-6.  High glucose-induced enhancement of CAP-evoked current is reversed with 
antioxidant treatment. (A) Example of CAP-evoked current trace from neurons in the high 
glucose condition treated with an antioxidant mixture containing 500 µM of lipoic acid and 
catalase (HG+ALA), which displayed a response that was neither monophasic nor biphasic 
following a series of CAP applications. Superimposition of these current traces is represented 
following every 3 applications of CAP. (B) The mean± SEM peak current density of the 6
th
 
CAP-evoked current for neurons treated in control, HG, HG + ALA and control + ALA, 
respectively. **p<0.01,  ***p<0.001, NS indicates no significant difference between conditions. 
 
 
 
 
CAP (5 M) 
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current traces from adult DRG neurons in both control and high glucose conditions displayed 
either a monophasic or biphasic response (Fig. 3-7A).   
Using the 50% threshold criterion, both control and high glucose conditions revealed a 
greater proportion of cells that displayed the monophasic response relative to the biphasic 
response (Fig. 3-7B); however, based on the small sample size, I cannot make any conclusive 
statements.  To compare the enhancement in TRPV1-mediated currents during high glucose (Fig. 
3-7C), I examined the peak current density and integrated area of Imax irrespective of the type of 
responses, due to the small sample size. The results in Fig. 3-8A, illustrate the mean peak current 
density of Imax CAP-evoked current in adult DRG neurons in control and high glucose conditions.  
Adult neurons in high glucose revealed a significant increase in the mean current density 
compared to that of control neurons (p<0.05, Fig. 3-8A), as shown in neonates (Fig. 3-4B). 
Conversely, no statistical differences were found for the integrated area of Imax CAP- evoked 
current in adult DRG neurons (Fig. 3-8B).  The reduced potentiated effect observed in the 
integrated area of CAP-evoked current in adults compared to neonates may be attributed to 
developmental changes.  However, similar to neonates, the degree of desensitization (Fig. 3-8C) 
and potentiation (Fig. 3-8D) was unaffected by the high glucose insult. This suggests that high 
glucose influences the magnitude of current in TRPV1 following repetitive activation, but does 
not influence mechanisms for desensitization or potentiation. 
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Figure 3-7.  Adult DRG neurons also displayed monophasic and biphasic responses in 
TRPV1-mediated currents under control and HG conditions. (A) Whole-cell current traces 
from adult DRG neurons also exhibited monophasic and biphasic responses from repetitive 
applications of CAP. (B) Bar graph summarizes the distribution of monophasic (black) and 
biphasic (white) response in control and HG conditions. (C) The difference in current influx 
between conditions is depicted by the overlap of Imax current traces from control (black) and HG 
(red) in the monophasic (left) and biphasic (right) responses. 
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Figure 3-8.  Adult DRG neurons also show enhancement in TRPV1-mediated current for 
peak current density but not integrated area.  Bar graphs summarizes the mean± SEM current 
density (A) and integrated area (B) of the Imax CAP-evoked current for neurons treated in control 
and HG conditions. *p<0.05.   Bar graphs (C and D) summaries the mean± SEM percentage of 
desensitization and potentiation in TRPV1-mediated currents from control and high glucose 
conditions with respect to the monophasic and biphasic responses.  
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3.4 Discussion 
Although glucose-mediated mechanisms leading to oxidative stress in sensory neurons as 
a result of hyperglycemia have been demonstrated to contribute to the pathogenesis of diabetic 
sensory neuropathy, very little is known of the cellular and molecular mechanisms influenced by 
elevated cytoplasmic ROS and its effects on the functional activity of the neuron.  In the present 
study, I demonstrated that a high glucose insult of 25 mM for 7 days generated high levels of 
cytoplasmic ROS in neonatal DRG neurons compared to basal glucose levels of 5 mM in the 
control condition.  This in turn enhanced the CAP-evoked current in both monophasic and 
biphasic responses, while having no influence on P2X-mediated currents.  Furthermore, I have 
shown that the mechanisms driving desensitization or potentiation in the monophasic and/or 
biphasic responses of the TRPV1 receptor were unaffected under high glucose conditions.   
However, the enhancement of TRPV1-mediated currents was reversed when cytoplasmic ROS 
levels were reduced with an antioxidant mixture containing -lipoic acid and catalase.  
Collectively, these findings demonstrated the influential role of hyperglycemia-induced oxidative 
stress in facilitating TRPV1 activity and its implications on the onset of DSN.  More importantly, 
I show that the redox state of the sensory neuron, in particular, can influence the functional 
activity of TRPV1 receptors. 
 
3.4.1 P2X receptors are unaffected by high glucose-induced oxidative stress 
Evidence from genetic and pharmacological approaches in the deletion or down 
regulation of P2X3 receptors revealed the importance of this receptor subtype in pain processing 
involved in thermal and mechanical nociception (reviewed by Jarvis, 2003).  Information on the 
influence of hyperglycemia- induced oxidative stress on the functional activity of this receptor 
subtype remains limited in literature.  In the current study, I demonstrated that repeated 
application of ATP evoked a fast-inactivated current resembling the kinetics of the P2X3 
receptor subtype (Grubb & Evans, 1999), confirming that this subtype is the dominant P2X 
receptor in small to medium size DRG neurons.  While the findings demonstrated no change in 
the P2X-mediated currents following seven days of the high glucose insult, this suggested that 
the P2X receptor was not affected under oxidative stress.  It is possible that long-term exposure 
of high glucose may be required to see an effect as demonstrated in streptozotocin (STZ) models 
of diabetes, which revealed an increased expression and function of P2X2 and/or P2X3 receptors 
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that paralleled the onset of hyperalgesia in diabetic mice 2 weeks after STZ injections (Migita et 
al., 2009) and rats (Gy, Li, Liu & Huang (2011).  Whether prolonged exposure to the high 
glucose insult (i.e. greater than 7 days) influences the functional activity of P2X receptors in 
sensory neurons in vitro may need to be evaluated.   
 
3.4.2 High glucose enhanced TRPV1-mediated currents  
 The influence of hyperglycemia on TRPV1 receptors expressed in sensory neurons have 
been studied in animal models with long standing diabetes induced by STZ (Pabbidi et al., 2008 
a; Bishnoi et al., 2011).  A common observation in these studies is that a small number of STZ-
induced animals were not hyperglycemic but displayed hyperalgesia upon behavioural testing.  
Pabbidi et al (2008b) had demonstrated that DRG neurons in culture exposed to STZ generated 
high levels of ROS, and was associated with an increase in TRPV1 activity and expression 
independent on the glycemic state, suggesting that STZ is a confound variable to consider.   
In our in vitro model, I investigated the effect of high glucose on TRPV1-mediated 
currents.  In the current study, the effects of high glucose on these currents (i.e. monophasic and 
biphasic responses), which were characterized in Chapter 2, were examined.   Interestingly, the 
two types of responses persisted in the high glucose condition, suggesting that these responses 
are an inherent property of TRPV1 receptors occurring independently of treatment conditions.  It 
was interesting to find that the mechanisms of desensitization or potentation observed in the 
monophasic and/or biphasic responses of TRPV1 behaviour were unaffected under the high 
glucose condition, but that quantitative analysis of the current influx revealed a robust 
enhancement for both the peak current density and integrated area under high glucose.  This 
suggests that in the high glucose condition cells are more responsive to pain stimulation, such 
that a greater magnitude of membrane current is observed in TRPV1 receptors.  Similarly, this 
enhancement of the current was also reported in DRG neurons of STZ-induced diabetic rats 
revealing an increase in peak amplitude and the duration of current influx (Hong & Wiley, 
2005).  In contrast, oxidative modulation of TRPV1 receptor was reported to slowly sensitize 
TRPV1-mediated currents in the presence of hydrogen peroxide in HEK cells through covalent 
modification of cysteine residues forming inter-cysteine disulfide bonds in the cytoplasmic 
termini of the receptor (Chuang & Lin, 2009).  Although this study did not show desensitization 
in TRPV1-mediated currents, the authors postulated that the potentiated TRPV1 
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receptor may not desensitize.  Conversely, the present study demonstrated that high glucose 
enhanced the CAP-evoked current, which was mediated by cytoplasmic ROS, but had no 
influence on the type of response (i.e. monophasic and biphasic) and its desensitization.  
 In addition to characterizing this robust enhancement in the monophasic and biphasic 
responses, I further show that the increase in CAP-evoked current was strongly driven by 
calcium influx.   This revealed that the calcium influx affected the type of responses to CAP and 
the desensitization as described in Chapter 2.  Here, I demonstrated that calcium was essential 
for the enhancement of CAP-evoked currents in the high glucose condition.  Because the influx 
of current in the barium experiment reflected barium influx as well as other monovalent ions 
(Comunanza et al., 2011), quantitative analysis of the difference in calcium influx without the 
inclusion of  the barium current could not be done.   Interestingly, a common observation in type 
1 and type 2 animal models of long standing diabetes is the high resting intracellular calcium 
concentrations in DRG neurons (reviewed by Fernyhough & Calcutt, 2011).  Whether the 
calcium-mediated potentiation of TRPV1 instigates this calcium abnormality phenomenon 
remains to be explored.   
 
3.4.3 Antioxidants reversed the enhancement of TRPV1-mediated currents 
The approach of using antioxidants to prevent oxidative stress and the progression of 
DSN has shown to be a therapeutic avenue for promoting neuronal protection and survival 
(Vincent et al., 2005b; Vincent et al., 2009).  However, denotation of the influence of 
antioxidants on the functional activity of sensory neurons has been limited in the literature.  In 
the present study, I have demonstrated that elevation of cytoplasmic ROS, induced by the high 
glucose insult in DRG neurons in TRPV1 current.  This effect was reversed  by antioxidants  -
lipoic acid and catalase in the recording pipette. While antioxidants might be a useful strategy to 
alleviate oxidative stress and the enhancement in TRPV1-mediated currents, as demonstrated in 
the present study, it should be acknowledged that I observed a change in the behaviour of 
TRPV1-mediated currents in both control and high glucose neurons treated with the antioxidants.  
This suggests that the redox state of the neuron influences the sensitivity of TRPV1 receptors 
prior to exposure to a stimulus.   It is possible that ROS-mediated oxidation also influenced other 
substrates and their activity within the cytoplasm.  Mild oxidation in neurons has been shown to 
mediate thiol oxidation in PKC and increase the kinases’ activity (Knapp & Klann, 2000).   In 
 56 
 
 
examining the influence of PKC activity in the biphasic response reported in Chapter 2, I 
demonstrated that application of a PKC  inhibitor drastically enhanced the degree of 
desensitization of the monophasic response, in which currents displayed an initial large inward 
current followed by a second inward current that was half the size and gradually desensitized 
following repeated applications of CAP.  This current response resembled the current responses 
obtained in the present study when high glucose and control (trace not shown) neurons were 
treated with antioxidants.  It is possible that the presence of antioxidants can reduce PKC activity 
and subsequently alter the competition between kinases and phosphatases (i.e. calcineurin) that 
would normally influence the potentiation or desensitization of TRPV1 receptors upon CAP 
applications.   Because intracellular application of antioxidants only evoked one type of response 
in TRPV1 function from a small sample of high glucose neurons, it remains unknown whether 
this reduced effect abolished both the monophasic and biphasic responses or if increasing the 
sample size would reveal two distinct responses, similar to the findings in the PKC  experiment 
and consistent with the observations that there are two functionally distinct populations of 
neurons.  Collectively, these findings suggest that the redox state of the sensory neuron can 
influence TRPV1 activity, and possibly the distribution of the monophasic and biphasic 
responses observed.  Certainly, the mechanisms and implications of these current responses will 
need to be addressed in future studies. 
 
3.4.4 Age-related vulnerability to oxidative stress and its influence on TRPV1- mediated 
currents 
It has recently been shown that TRPV1 receptor expression is maintained post 
development in peptidergic neurons, while down-regulated in nonpeptidergic neurons 
(Cavanaugh et al., 2011).  To show that ROS-mediated enhancement in TRPV1 receptors 
occurred regardless of development, transgenic mice that express the fluorescent marker GFP in 
neurons that express the CGRP promoter was used to selectively identify CGRP-positive 
peptidergic neurons in culture.  Consistent with neonates, repeated applications of CAP revealed 
the monophasic and biphasic responses in both control and high glucose conditions.  
The influence of the high glucose insult on adult DRG neurons revealed a different 
enhancement in TRPV1-mediated currents.  In the present study, it was observed that this effect 
was largely attributed to the peak amplitude but had no effect on the integrated area in adult 
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DRG neurons. However, due to the low sample size, analysis was conducted to compare control 
and high glucose conditions irrespective of the type of response.   The differential effect in adults 
may be attributed to this factor, which makes it difficult to draw definitive conclusions. 
Increasing sample size will help study the difference between neonates and adults.  
 
3.5 Conclusion 
In summary, the results provide evidence that elevation of cytoplasmic ROS in DRG 
neurons as a result of high glucose causes the enhancement of TRPV1 currents following 
repeated applications of capsaicin, while having no influence on P2X receptors. This effect on 
TRPV1 was reversed when cells were exposed to an intracellular antioxidant mixture. This 
specific oxidation of the TRPV1 channel and not P2X receptor constitutes a mechanism leading 
to an increase in the functional activity of sensory neurons and in the onset of diabetic sensory 
neuropathy. 
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CHAPTER 4 
GENERAL DISCUSSION 
 
4.1. Summary of main findings 
In the present thesis, two studies were conducted to examine the influence of high 
glucose on P2X and TRPV1 receptors in dissociated lumbar DRG neurons in culture.  While 
investigating the role of TRPV1, two types of responses were observed following repetitive CAP 
applications under the control condition: (1)  a ‘monophasic response’ with a diminuation of 
peak current typical of tachyphylactic desensitization; or (2), a ‘biphasic response’ composed of 
an initial gradual potentiation of the peak current followed by its desensitization by 
tachyphylaxis.  The latter response was a novel observation that prompted further investigations 
in Chapter 2.   I demonstrated that the initial CAP-evoked current could help identify the 
monophasic and biphasic responses.  In addition, it was observed that the degree of 
desensitization was similar between responses, which suggested a common desensitization 
mechanism.  Furthermore, inhibition of PKC , a PKC isoform that has been implicated in 
diabetic hyperalgesia, prevented the potentiation that was characteristic of the biphasic response, 
suggesting that this isoform of PKC mediated the potentiation phenomenon in the biphasic 
response.   
Following the characterization of the two types of responses to repetitive CAP 
applications under control conditions, the influence of oxidative stress during high glucose on the 
monophasic and biphasic responses of TRPV1 receptors were examined in Chapter 3.  Both 
TRPV1 responses were enhanced under high glucose conditions without affecting the 
desensitization and/or potentiation in the monophasic or biphasic response.  This suggested that 
the TRPV1 receptor may play a role in mechanisms of diabetic sensory neuropathy.  In contrast, 
P2X-mediated currents remained unaffected by the high glucose condition.  It is possible that a 
longer period of high glucose is required to see the effects on P2X receptor that has been 
reported in animal models of long-standing diabetes (Migita et al., 2009; Gy et al., 2011).   
To further explore the enhanced effect in TRPV1-mediated currents under high glucose, 
additional experiments were conducted.  I demonstrated that this enhanced phenomenon was 
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greatly dependent on calcium influx.  Furthermore, antioxidant treatment in neurons that have 
been exposed to high glucose for a week reversed the enhancement in current influx; however, a 
secondary effect was observed in that these currents were neither monophasic nor biphasic in 
response.  This suggested that the redox state of the cell may influence the type of responses (i.e. 
monophasic or biphasic) in TRPV1 receptors.  Lastly, I also demonstrated that adult nociceptive 
neurons also exhibit the monophasic and biphasic responses in both control and high glucose 
conditions.  Despite the small sample size, these cells displayed a differential effect on the 
enhancement of CAP-evoked currents that was not as robust as neonates.  This suggested that the 
difference in the effect of oxidative stress on TRPV1 receptors may be attributed to age-related 
vulnerability and the antioxidant capacity as it was previously described for central neurons 
(Ferriero, 2001; Aycicek & Iscan, 2006; Perrone et al., 2010).   
Collectively, these experiments revealed that the intrinsic properties of the cell (i.e. 
calcium-dependent endogenous activators, and the redox state) can influence the monophasic and 
biphasic responses of TRPV1 receptors under control and diabetic conditions.  In addition, I 
demonstrated that the TRPV1 receptors are affected by the high glucose insult as early as 7 days, 
suggesting that this receptor could be involved in the onset of diabetic sensory neuropathy. 
 
4.2 Intrinsic properties of the sensory neuron that can influence the function of TRPV1 
receptors 
 
4.2.1 Biphasic response of TRPV1 receptor is regulated by phosphorylation of PKC  
 
In Chapter 2, the unexpected observation that TRPV1 receptors can respond in two ways 
(i.e. monophasic and biphasic) following repetitive applications of CAP was a novel finding that 
prompted further investigations to characterize these responses before examining the receptor 
under the high glucose condition.  Several hypotheses were introduced to explain the mechanism 
regulating the monophasic and biphasic response of TRPV1 receptors under the control 
condition, independent of inflammatory mediators.  It was proposed that the type of response 
was regulated by the phosphorylated or dephosphorylated state of the receptor prior to CAP 
applications (refer to 2.4.2).  Based on the PKC  experiment, it appeared that the potentiated 
phenomenon in the biphasic response was mediated by PKC  activity, since 
60 
 
inhibition of this kinase abolished the potentiation phenomenon.  Similarly, inhibition of PKC  
revealed a robust desensitization phase in the monophasic response suggesting that a basal level 
of PKC  activity is required for the gradual desensitization observed in the monophasic 
response.  Furthermore, it would be interesting to understand the implications of the monophasic 
and biphasic response in the presence of other noxious stimulus (i.e. pH, proinflammatory 
mediators, temperature and etc) that regulate TRPV1 receptors.  Thus, providing a greater 
understanding of how these responses would contribute in an animal that is feeling pain.  For 
example, does the biphasic response act as a backup sensory system to allow for the detection of 
potential nociceptive stimuli when neurons displaying the monophasic response have already 
been desensitized? 
 
4.2.2 Effect of cytoplasmic ROS on TRPV1 receptors 
In recent studies, acute exposures to mild oxidants have shown to influence the sensitivity 
of the TRPV1 receptors expressed in HEK cells, increasing the membrane current following 
repeated exposure to the receptor’s agonist (Susankova et al., 2006; Chuang & Lin, 2009).  This 
suggested that oxidative stress may also regulate TRPV1 receptors in pain processing during 
inflammation, inflection and tissue injury, all conditions associated to oxidative stress.  However, 
the influence of mild oxidants or oxidative stress on native TRPV1 receptors in DRG neurons 
has not been examined to date.  In the present thesis, elevated ROS as a result of prolonged 
exposure to high glucose revealed three things:  1) oxidative stress influenced the magnitude of 
CAP-evoked current through the receptor; 2) oxidative stress may alter PKC  activity and 
subsequently affect TRPV1 receptors; and 3) age-related vulnerability to oxidative stress 
influenced the degree of enhancement in membrane current during high glucose.  
 
4.2.2.1 Oxidative stress influences the magnitude of current through TRPV1 receptors 
 In the present thesis, it was demonstrated that high glucose-induced oxidative stress 
enhanced the calcium-dependent membrane current generated from repeated applications of CAP 
without affecting the monophasic or biphasic response in TRPV1 receptors.  Because the 
parameters of the monophasic and biphasic responses in native TRPV1 receptors remained 
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unaffected by high glucose, this contrasted with recent reports that demonstrated that TRPV1 
receptors overexpressed in HEK cells and exposed to ROS always displayed a gradual 
potentiation in the membrane current resembling the biphasic response (Susankova et al., 2006; 
Chuang & Lin, 2009).  It is possible to consider that the length of time the sensory neuron is 
exposed to the mild oxidant could influence the type of potentiation in TRPV1 receptors 
following repetitive activation.  While the aforementioned studies exposed cells to approximately 
2 minutes of the mild oxidant, the present thesis examined sustained oxidative stress conditions 
(induced by 7 days in high glucose) in the in vitro diabetes model (Vincent et al, 2005).  
Nevertheless, it is plausible to suggest that acute or long-term oxidative stress have a differential 
effect on TRPV1 function.  However, the mechanism that triggers the enhancement of current 
observed during high glucose-induced oxidation in the present thesis remains poorly understood.   
Recently, it was revealed that as in other calcium-permeable channels (e.g. TRPA1 and 
P2X receptors, Banke et al., 2010 & 2011; Virginio et al., 1999) pore dilation plays a role in 
TRPV1 receptors.  Repetitive CAP application led to the calcium-dependent pore dilation of the 
TRPV1 receptors, permeating large fluorescent molecules (i.e.Yo-PRO-1) in cells (Bautista & 
Julius, 2008; Chen et al., 2009; Li et al., 2011).  It is possible to consider that the mechanism for 
pore dilation is enhanced for cells exposed to the high glucose insult, thereby allowing a greater 
volume of charge through the ion channel following repeated applications of CAP.  Although, 
the mechanisms that regulate pore dilation of TRPV1 receptors remain unclear, pathological 
conditions could contribute to this effect, sensitizing sensory neurons to noxious stimuli.  Here, I 
show that reducing cytoplasmic ROS levels prevented the enhancement of current influx in high 
glucose conditions.  It would be interesting to investigate in future experiments whether 
pathological signals linked to high glucose could trigger pore dilation of TRPV1 and how that 
plays a role in the context of diabetes. 
4.2.2.2 Oxidative stress may modulate TRPV1 receptors through PKC  activity 
 An interesting observation was found in the PKC  study in which cells that exhibited the 
monophasic response under the influence of the PKC  inhibitor were comparable in their 
responses to DRG neurons exposed to antioxidants.  It has been reported that ROS can increase 
PKC activity through thiol oxidation (Knapp & Klann, 2000; Lin & Takemoto, 2005).  Indeed, it 
is possible that oxidative stress and the generation of ROS can not only influence membrane 
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receptors (i.e. TRPV1) but also endogenous activators (i.e. PKC) that regulate them, leading to 
amplification in receptor activity. Based on the present thesis it remains unknown
whether the current traces generated in the presence of the antioxidants were due to isolated or a 
combination of events involving reducing agents targeting the TRPV1 receptor and/or PKC 
activity.    
4.2.2.3 Age-related vulnerability to oxidative stress influences the degree of enhancement in 
membrane current  
 
 Although the mechanism by which oxidative stress enhanced the membrane currents of 
TRPV1 remains unclear, my data indicates that the degree of enhancement was dependent on the 
age of the DRG neurons in culture, suggesting age-related vulnerability to oxidative stress.  
Studies investigating cerebral ischemia, epilepsy, and mitochondrial disorders in newborns have 
suggested a reduced antioxidant capacity to regulate oxidative stress in central neurons (Ferriero, 
2001; Aycicek & Iscan, 2006; Perrone et al., 2010).  Under the high glucose insult, a greater 
degree of enhancement was observed for neonatal DRG neurons relative adult DRG neurons.  It 
is possible that neonatal DRG neurons under the high glucose insult greatly diminished its 
antioxidant capacity within 7 days of treatment, while adult DRG neurons retained some of its 
antioxidant capacity to reduce oxidative stress.  In addition, it would suggest that a longer 
exposure to high glucose in adult DRG neurons may show reproducible results similar to 
neonatal DRG neurons observed in the present thesis, as well as studies that have examined 
animal models of long-term diabetes. 
4.3 Future Directions 
 
4.3.1 Calcium imaging to parallel electrophysiological recordings in understanding the role 
of TRPV1 in physiological and high glucose conditions 
 A number of electrophysiological studies dating back to the late 1980s have identified the 
influential role of calcium in regulating TRPV1 activity (Wood et al., 1988; Petersen et al., 1996; 
Oh et al., 1996; Koplas et al., 1997).  In Chapter 2, based on the characterization of the 
monophasic and biphasic responses it cannot be excluded that intracellular calcium may 
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influence TRPV1 function playing a role in the generation of these two responses.  To study 
whether intracellular calcium contributes to the monophasic and biphasic responses we plan to 
use time-lapse calcium imaging to measure the spatial and temporal profiles of induced changes 
in the intracellular calcium concentrations.  The combining of this data with my 
electrophysiological findings would shed light on the influential role of intracellular calcium on 
the behaviours of TRPV1 receptors.  Certainly, previous studies have used this method to 
measure changes in intracellular calcium concentrations as a result of activating TRPV1 in the 
presence of pharmacological manipulations on the receptor (Honan & McNaughton, 2007; 
Sculptoreanu, Kullmann & de Groat, 2008; Zhang et al., 2010).   
Moreover, in Chapter 3, it was demonstrated that there was an enhancement in TRPV1-
mediated currents that was calcium dependent under the influence of high glucose, based on the 
observation made from the barium experiment.  The use of this technique can further address or 
explore issues generated from the current thesis: 1) Is a high glucose insult of at least 7 days 
capable of inducing a dysfunction in intracellular calcium homeostasis as reported in long 
standing diabetes model of type 1 and type 2 (Fernyhough & Calcutt, 2010); and 2) Is the 
enhanced effect of TRPV1 receptor influenced by the dysfunction of intracellular calcium 
homeostasis or is the effect solely mediated by ROS-oxidation of TRPV1 receptors.  
 In summary, this thesis presented novel insights in the role of high glucose-induced 
oxidative stress on the functional modification of TRPV1 receptors in sensory neurons.  Here, I 
show that TRPV1 receptors exhibited two types of responses in the control condition (Figure 4-
1A).  For the monophasic response, application of CAP changes the conformation of the TRPV1 
channel from a closed to an open state allowing the influx of current.  As previously described, 
entry of calcium or calcium dependent phosphatase mediates the desensitization phenomenon 
displayed by the run-down in peak current (Docherty et al., 1996; Koplas et al., 1997). Similarly, 
for cells that responded in a biphasic response, application of CAP opened the channel allowing 
the influx of current, however, I demonstrated that the potentiated phenomenon was mediated by 
PKC .   Under high glucose treatment, which resulted in the elevation of cytoplasmic ROS, I 
demonstrated that the magnitude of current generated through TRPV1 channel was enhanced 
following a series of CAP applications for both the monophasic and biphasic responses (Fig. 4-
1B). But had no influence on the mechanism that mediated the desensitization or potentiation 
that was characteristic of the responses.  Furthermore, I have shown that reducing  
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Figure 4-1.  Proposed working models for the funcational states of TRPV1 receptors under 
control and high glucose conditions.  (A) A series of CAP applications evoked two types of 
responses in TRPV1 activity: a monophasic (left) and biphasic (right) response, which is 
represented by the current traces. For the monophasic response, application of CAP changes the 
conformation of the channel from a closed to an open state allowing the influx of current, where 
entry of calcium or calcium dependent phosphatase mediates the desensitization phenomenon. 
Similarly, for cells that responded in a biphasic response, application of CAP opened the channel 
allowing the influx of current, however, PKC  mediated the potentiation phenomenon. (B) 
Under high glucose treatment, which resulted in the elevation of cytoplasmic ROS, the 
magnitude of current influx was enhanced for both the monophasic and biphasic responses. But 
had no influence on the mechanism that mediated the desensitization or potentiation that was 
characteristic of the responses.  (C) While reducing ROS reversed this enhancement as a result of 
high glucose, however, the sensitivity of TRPV1 channels as the current responses was neither 
monophasic nor biphasic. 
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cytoplasmic ROS reversed this enhancement as a result of high glucose, however, affected the 
sensitivity of TRPV1 channels as the current responses was neither monophasic nor biphasic 
(Fig.4-1C). These findings suggest that the redox state of the cell influences TRPV1 activity and 
collectively correlate with the pathological environment reported in diabetes, and therefore may 
have implications in pain perception and processing in the diabetic state. 
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